Finex logo
Finex Intelligence

Market Signal Briefing

Wire-ready dashboard awaiting your first source connection.

Last news saved at Mar 30, 13:54 12d ago Cron last ran Mar 30, 13:54 12d ago Awaiting first source
Switch language
91,488 Stories ingested Auto-fetched market intel nonstop.
0 Distinct tickers Add sources to start tracking symbols
Trending sources Waiting for fresh intel
Hot tickers Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-12-30 17:06 3mo ago
2025-12-30 12:00 3mo ago
Hartford Insurance Up 27% in a Year: Does the Rally Still Have Legs? stocknewsapi
HIG
Key Takeaways HIG shares gained 27% in a year, beating both the industry and the S&P 500.HIG's 2025 EPS is estimated to rise 20.8%, supported by steady estimate revisions.HIG boosted returns with buybacks and dividends, though leverage remains a watch point.
Shares of The Hartford Insurance Group, Inc. (HIG - Free Report) have delivered an impressive 27% return over the past year, comfortably outperforming the industry’s 9.7% gain and the S&P 500’s 19.5% rise. The rally has been fueled by solid operating execution, steady growth in earned premiums and a supportive investment income backdrop.

Price Performance – HIG vs. Industry & S&P 500 Image Source: Zacks Investment Research

Based in Hartford, CT, the company provides a broad suite of insurance and financial services across domestic and international markets. With a market capitalization of $38.6 billion, HIG currently carries a Zacks Rank #3 (Hold). The key question now is whether the stock can sustain its momentum and deliver incremental upside from current levels.

Let’s take a closer look.

The Zacks Consensus Estimate for 2025 EPS stands at $12.44, implying a strong 20.8% year-over-year increase, followed by 4.5% growth in 2026 to $13. It has witnessed one upward estimate revision in the past month, against no downward movement. HIG has also established a consistent earnings beat record, surpassing estimates in each of the last four quarters with an average surprise of 14.3%.

For the top line, 2025 estimates are pegged at $19.9 billion, implying 9.1% growth from the prior year. Revenues are expected to remain on an upward trajectory in 2026, with the consensus estimate projecting a 7.6% year-over-year increase.

Strategically, Hartford Insurance has sharpened its focus on core businesses, disciplined underwriting and profitability enhancement. The divestiture of legacy run-off portfolios and non-core operations has streamlined the business, strengthened its risk profile and improved financial flexibility. At the same time, ongoing investments in digital tools and data science are enhancing platform capabilities and supporting customer acquisition and retention.

These efforts are clearly reflected in profitability metrics. HIG’s trailing 12-month return on equity stands at 21.07%, more than double the industry average of 8.02%, underscoring the company’s efficient capital deployment.

Operational restructuring initiatives, most notably Hartford Next, are also beginning to bear fruit. In the first nine months of 2025, the Employee Benefits segment posted a 10-basis-point improvement in core earnings margin, while the Business Insurance combined ratio improved by 70 basis points, signaling better underwriting discipline.

Capital returns remain another key pillar of the investment case. HIG has consistently rewarded shareholders through aggressive buybacks and steady dividends. The company repurchased $1.5 billion of shares in 2024, followed by $1.2 billion during the first nine months of 2025. As of Sept. 30, 2025, $1.95 billion remained under its current repurchase authorization. Additionally, Hartford returned $446 million in dividends over the first three quarters, supporting a dividend yield of 1.7%, well above the industry average of 0.3%.

Risks to MonitorDespite the positives, a few challenges warrant attention. Near-term improvements in the Personal Insurance segment are yet to translate into sustainable margin recovery, with cost pressure still elevated. The segment reported a combined ratio of 96.2% for the first nine months of 2025.

Balance sheet leverage is another consideration. As of the end of the third quarter, long-term debt totaled $4.4 billion, significantly exceeding the company’s cash balance of $150 million. Long-term debt represents 24.1% of total equity, well above the industry average.

That said, Hartford’s disciplined execution, strategic efforts and capital management strategy position it well for sustainable long-term growth, even as near-term risks remain in focus.

Key Picks in FinanceMeanwhile, investors interested in the broader finance space can look at companies like CNA Financial Corporation (CNA - Free Report) , Cincinnati Financial Corporation (CINF - Free Report) and HCI Group, Inc. (HCI - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for CNA Financial’s 2025 earnings is pegged at $4.86 per share. The consensus mark witnessed two upward estimate revisions in the past 60 days. Also, the consensus mark for CNA’s 2025 revenues of $13.53 billion suggests 6.2% year-over-year growth.

The consensus mark for Cincinnati Financial’s 2025 earnings is pegged at $7.21 per share. The estimate witnessed one upward estimate revision over the past month. The company beat earnings estimates in each of the past four quarters with an average of 52.4%. The consensus mark for Cincinnati Financial’s current year revenues is pegged at $11.19 billion, implying a 12.5% increase from a year ago.

The Zacks Consensus Estimate for HCI Group’s 2025 earnings indicates 173.8% year-over-year surge. Over the past 60 days, it has witnessed three upward revisions against none in the opposite direction. HCI Group’s current-year revenue estimates indicate an 18.9% increase from a year ago.
2025-12-30 17:06 3mo ago
2025-12-30 12:00 3mo ago
Markets Await Initial Claims Data stocknewsapi
FOMC
Stock market indexes have gotten a tad “Scroogey” following the earlier-than-expected Santa Claus rally last week. Yesterday, we saw a half-point drop amid low volume as investors booked gains at the end of another strong year. We’re still +21% on the Nasdaq year to date, and up double digits on the major indexes elsewhere.

We have seen lots of good news in what early on was shaping up to be a problematic 2025. Early April “Liberation Day” tariff initiatives notwithstanding (as they got rolled back in a hurry following a week of plummeting market returns), we’re so far averaging +2.5% GDP growth following Q3’s +4.3%, which was the healthiest economy we’ve seen since Q3 2023. In fact, the +2.5% we’re riding currently is a notch better than the +2.4% we saw through all of 2024.

That’s not to say there aren’t concerns on the horizon. Even though we saw a CPI Inflation Rate come down 30 basis points (bps) in the most recent print to a reasonable (but still not optimum) +2.7%, many analysts believe we are looking at incomplete data, and the Inflation Rate may be revised upward — perhaps by more than 30 bps — just as tariff effects begin to hit U.S. trade goods.

The employment situation is another source of concern. Even though we see benign prints in Weekly Jobless Claims, these tend to mask the low turnout in new hires, which are roughly -100K from where they were a year ago. Even as the retirement boom cools to sub-100K per month, we still do not appear to be covering for those exiting the workforce. And we’re not even counting recent graduates who remain unemployed months or years after leaving school; they were never considered part of the workforce to begin with.

Home Prices Improve in Yesterday’s ReportsWe saw both Pending Home Sales for November and Case-Shiller Home Prices for October yesterday, and both came in positive. For Pending Home Sales, we saw a surprise bump to +3.3% from the previous two months in negative territory, and +2.6% was the third-strongest in the past 12 months. Case-Shiller prices grew +1.1% this past fall, reversing three previous months of losses. This is good news for home sellers; not as much for those looking for further evidence that inflation is coming down.

What to Expect from the Market TodayAfter the opening bell, we’ll get a new installment from the Chicago Business Barometer. Here’s where we can use a bit of good news: last month’s +36.3% print was the lowest since May of 2024, and the 24th month below the 50-threshold between gain and loss. These numbers do tend to jump around a bit, but anything above +40% would likely be welcome.

The minutes from the last Federal Open Market Committee (FOMC) meeting are out as of 2pm ET today. These notes will highlight the differences in thinking regarding where interest rates ought to be headed: Fed Governor Stephen Miran — on loan from President Trump’s White House — for the thirds time in a row advocated a -50bps rate cut, while Fed Presidents from Chicago and Kansas City — Austan Goolsbee and Jeffrey Schmid — voted for no change to the Fed funds rate.

The smart money is currently on a pause at the next FOMC meeting in late January. The Fed skips February and moves to March with the subsequent meeting, so it will be anyone’s guess what happens then; so much is tied to inflation and employment reports, of which there with be several by March 18th. For today’s minutes, we look for confirmation of this sentiment, but of course will take note of any outliers.
2025-12-30 17:06 3mo ago
2025-12-30 12:03 3mo ago
Merck: A Post-2028 Slowdown Doesn't Kill The Long-Term Thesis stocknewsapi
MRK
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-12-30 17:06 3mo ago
2025-12-30 12:04 3mo ago
Four key drivers will determine gold's price trajectory in 2026 – WGC's Artigas stocknewsapi
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL
Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.
2025-12-30 17:06 3mo ago
2025-12-30 12:05 3mo ago
Can Amgen's MariTide Take on Leaders in the Obesity Space? stocknewsapi
AMGN
Key Takeaways Amgen completed MARITIME-1 and -2 enrollment, testing MariTide in 5,000 obesity patients.MariTide aims for monthly or less frequent dosing, showing sustained weight loss in studies.NVO won FDA approval for an oral Wegovy pill, raising competition as oral GLP-1s enter weight management.
Amgen (AMGN - Free Report) is one of the few companies with a late-stage obesity candidate in its pipeline. The company is developing MariTide, an investigational GLP-1/GIP receptor agonist, as part of its comprehensive MARITIME phase III program in obesity. With this drug, Amgen intends to take on Eli Lilly (LLY - Free Report) and Novo Nordisk (NVO - Free Report) , which currently dominate this space with their respective injectable GLP-1 therapies.

A key differentiator for MariTide is its long-acting profile. Unlike currently marketed GLP-1 drugs, such as Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy, which require weekly injections, MariTide is designed for monthly or potentially even less frequent dosing. Amgen has reported predictable and sustained weight loss, with clinically meaningful improvements in cardiometabolic parameters, in earlier studies, positioning MariTide as a potentially more convenient long-term treatment option in a market increasingly focused on adherence and durability.

Amgen is evaluating MariTide across a broad range of cardiometabolic indications, with obesity at the center of its development strategy. Enrollment has been completed in two pivotal late-stage studies — MARITIME-1 and MARITIME-2 — which are evaluating the drug in patients with obesity, with and without type II diabetes, respectively. Roughly 5,000 patients were enrolled across these studies in a relatively short time frame, underscoring strong investigator and patient interest in the program.

Apart from obesity, MariTide is also being studied in phase III studies for atherosclerotic cardiovascular disease and heart failure, as well as in obstructive sleep apnea. These indications could significantly expand the drug’s commercial potential if weight loss translates into downstream cardiometabolic and cardiovascular benefits, as suggested by earlier-stage data.

Market Leaders Continue to Raise the BarDespite MariTide’s differentiated dosing profile, the obesity treatment landscape is evolving rapidly. Recently, Novo Nordisk secured FDA approval for the pill version of Wegovy, marking approval for the first GLP-1 RA approved in an oral form for weight management. Compared with injectable formulations, the pill offers a far more convenient administration option, significantly lowering treatment burden and potentially improving patient adherence. Novo Nordisk expects to launch the Wegovy pill in early next month and has priced the drug at $149 per month for patients without insurance.

Eli Lilly is also moving quickly in this direction. Earlier this month, LLY submitted a regulatory filing seeking approval for its oral obesity candidate, orforglipron, setting the stage for a potential launch next year. The arrival of effective oral GLP-1 therapies raises the bar for differentiation and could reshape patient and physician preferences across the obesity market.

That said, this push for oral pills does not signal a retreat from injectables for either market leader. Eli Lilly continues to invest aggressively across next-generation obesity therapies with diverse mechanisms of action. Its pipeline includes orforglipron, a once-daily oral small-molecule GLP-1, as well as retatrutide, a triple-hormone (GIP/GLP-1/glucagon) agonist being developed as a next-generation injectable.

Novo Nordisk is similarly expanding its next wave of obesity treatments. It is advancing a next-generation therapy called amycretin, both as an injectable and an oral formulation. NVO plans to initiate a phase III program for amycretin in the first quarter of 2026, reinforcing its strategy of maintaining leadership across multiple modalities rather than relying on a single product class.

AMGN’s Price Performance, Valuation and EstimatesShares of Amgen have outperformed the industry year to date, as seen in the chart below.

Image Source: Zacks Investment Research

From a valuation standpoint, Amgen is trading at a discount to the industry. Based on the price/earnings (P/E) ratio, the company’s shares currently trade at 15.20 times forward earnings compared to the industry's average of 17.56. The stock is trading above its five-year mean of 13.76.

Image Source: Zacks Investment Research

EPS estimates for 2025 and 2026 have risen in the past 60 days.

Image Source: Zacks Investment Research

Amgen currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2025-12-30 17:06 3mo ago
2025-12-30 12:05 3mo ago
Will Alibaba Stock Recover Amid Slowing E-Commerce Market Momentum? stocknewsapi
BABA
Key Takeaways Alibaba posted 5% revenue growth in Q2 FY26. Non-GAAP EPS fell 71% and income dropped 85% on investment.China commerce growth relied on subsidies and marketing spend as rivals PDD, JD.com and Douyin gained share.Alibaba's expansion drove negative free cash flow, raising concerns over sustaining AI and subsidy spending.
Alibaba (BABA - Free Report) confronts persistent headwinds in its core e-commerce operations despite management's aggressive pivot toward artificial intelligence investments. The company reported 5% year-over-year revenue growth to RMB247.8 billion in its second quarter of fiscal 2026, but this modest expansion masks troubling deterioration in profitability metrics.

Non-GAAP earnings plunged 71% year over year to RMB4.36 per American Depositary Share, significantly underperforming analyst expectations by approximately 20%. Operating income plunged 85% from RMB35.2 billion to just RMB5.4 billion, reflecting the substantial margin compression from strategic investments.

The China commerce segment faces intensifying competitive pressure from PDD Holdings, ByteDance's Douyin and JD.com, forcing Alibaba into costly defensive strategies. While local e-commerce revenues expanded 16% during the fiscal second quarter, supported by government consumption stimulus measures, this growth required elevated marketing expenditure and aggressive subsidies through the company's "10-Billion Subsidy" program. Management emphasized optimization of quick commerce unit economics, achieving a 50% reduction in per-order losses since mid-2025, yet these improvements remain insufficient to offset broader margin degradation.

In December 2025, Alibaba announced expanded instant commerce infrastructure through its Cainiao logistics arm, planning new or expanded warehouses across 31 mainland Chinese cities by January 2026 to enable four-hour grocery deliveries. However, this infrastructure investment compounds capital expenditure concerns, with the company already reporting RMB21.8 billion negative free cash flow last quarter, driven by an 80% year-over-year increase in capital spending. The balance sheet deterioration raises questions about Alibaba's ability to sustain simultaneous investments in AI infrastructure, quick commerce logistics and margin-eroding subsidies while defending against relentless competitive encroachment in its traditional e-commerce stronghold.

Rivals Navigate Infrastructure ExpansionAmazon (AMZN - Free Report) has aggressively accelerated its quick commerce footprint throughout late 2025, establishing over 300 micro-fulfillment centers across India's major metropolitan areas. Amazon's "Amazon Now" service promises 10-minute deliveries across select areas in Bengaluru, Delhi and Mumbai, with daily orders growing 25% month over month since the September 2025 expansion. The e-commerce giant announced in December 2025 plans to open two new dark stores daily, targeting 300 total facilities by year-end, exclusively in its three operating cities. Amazon's infrastructure investments remain substantial yet focused, concentrating resources on high-density urban markets where Prime membership penetration provides customer acquisition advantages.

Meanwhile, JD.com (JD - Free Report) surpassed 700 million annual active customers in October 2025, driven partly by its JD NOW instant retail platform. It delivered products in as fast as nine minutes from over 500,000 physical stores across 2,300 Chinese counties and cities. JD.com achieved sequential investment reduction in its food delivery business during the third quarter, demonstrating improved unit economics performance that contrasts sharply with Alibaba's mounting losses. JD.com's November 2025 Singles' Day performance showcased 40% year-over-year growth in shoppers and nearly 60% order volume increases, with 95% of retail orders fulfilled within 24 hours.

Both Amazon and JD.com face similar infrastructure cost pressure as Alibaba, yet appear better positioned to absorb expansion expenses, given stronger baseline profitability and more disciplined capital allocation strategies.

BABA’s Share Price Performance, Valuation and EstimatesBABA shares have surged 30.3% in the past six-month period, outperforming the Zacks Internet – Commerce industry and the Zacks Retail-Wholesale sector’s growth of 4.2% and 3.1%, respectively.

BABA’s 6-Month Price Performance
Image Source: Zacks Investment Research

From a valuation standpoint, BABA stock is currently trading at a forward 12-month price/sales ratio of 2.23X compared with the industry’s 2.14X. BABA has a Value Score of D.

BABA’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for fiscal 2026 earnings is pegged at $6.42 per share, implying a 28.7% year-over-year decline.
2025-12-30 16:06 3mo ago
2025-12-30 09:57 3mo ago
Metaplanet Spends $451 Million on 4,279 Bitcoin in Q4 cryptonews
BTC
Metaplanet added 4,279 bitcoin during the fourth quarter of this year, spending about $451 million and lifting its total holdings to 35,102 BTC, the company said Tuesday.

The purchase reinforces the Tokyo-listed firm’s position as one of the largest corporate bitcoin holders in Asia and the fourth largest among publicly traded companies globally.

The bitcoin was acquired at an average price of $105,412 per coin, according to the company. Metaplanet has now spent roughly $3.78 billion accumulating bitcoin at an average cost of about $107,600. 

The firm has set an ambitious target of owning 210,000 BTC by the end of 2027, a goal that implies continued reliance on capital markets and credit facilities to fund future purchases.

Metaplanet’s shares ended the year up about 8% at 405 yen, though they remain far below the peak reached in June, when the stock traded near all-time highs. 

The gap reflects both the volatility of bitcoin prices and investor unease around balance sheets that are tightly linked to a single asset. For shareholders, the strategy offers leverage to bitcoin’s upside while exposing the company to drawdowns that can move faster than operating income.

Metaplanet’s bitcoin accumulation via consistent revenue  Unlike some bitcoin treasury firms, Metaplanet has paired accumulation with a separate income generation business built around derivatives. The unit aims to produce recurring revenue while supporting long-term bitcoin holdings. 

The company expects this business to generate around $55 million in revenue in the coming fiscal year, a figure that helps frame its strategy as more than passive holding.

During the quarter, Metaplanet reported a BTC Yield of 11.9%, a metric it uses to measure bitcoin accretion on a per-share basis. 

Year to date, the company reported BTC Yield of more than 500%, helped by rising bitcoin prices and the pace of purchases. 

The fourth-quarter buying spree followed a pause that began in late September, the longest break in Metaplanet’s acquisition program since it adopted a bitcoin treasury strategy. 

Funding for recent purchases has included bitcoin-backed credit facilities totaling about $280 million and the issuance of Class B preferred shares convertible into common stock. 

The company said proceeds from the preferred share sale will be used largely to buy more bitcoin, with a portion set aside for yield strategies and bond redemptions.

Bitcoin currently trades at $88,590, up 1% on the day, with $36 billion in volume and a $1.76 trillion market cap as it hovers near recent weekly highs.

Micah Zimmerman

Micah first discovered Bitcoin in 2018 but remained a skeptic on the sidelines for too long. Since 2021, he has covered crypto and business and now works as a news reporter for Bitcoin Magazine, based in North Carolina.
2025-12-30 16:06 3mo ago
2025-12-30 09:57 3mo ago
ALGO Price Prediction: Targeting $0.14 Breakout Within 7 Days as Technical Indicators Signal Recovery cryptonews
ALGO
Rongchai Wang
Dec 30, 2025 15:57

Our ALGO price prediction targets $0.14 (+17%) within one week as oversold RSI and bullish MACD divergence suggest Algorand is primed for a technical bounce from current levels.

ALGO Price Prediction Summary
• ALGO short-term target (1 week): $0.14 (+16.7% from current $0.12)
• Algorand medium-term forecast (1 month): $0.11-$0.16 trading range
• Key level to break for bullish continuation: $0.14 resistance
• Critical support if bearish: $0.11 (52-week low territory)

Recent Algorand Price Predictions from Analysts
The latest ALGO price prediction consensus from major analysts shows cautious optimism despite recent price weakness. AInvest News leads with the most bullish Algorand forecast, targeting $0.14 based on oversold RSI conditions at 37.41 and emerging MACD divergence patterns. This represents the highest confidence prediction among recent analysts.

CoinCodex and Changelly both project more conservative targets near $0.118-$0.119, reflecting the current "Extreme Fear" market sentiment with the Fear & Greed Index sitting at just 23. However, their lower confidence ratings suggest these may be overly pessimistic given the technical setup.

The analyst consensus converges on the $0.14 resistance level as the primary ALGO price target for the next week, representing a critical test of whether Algorand can break out of its current consolidation pattern.

ALGO Technical Analysis: Setting Up for Bullish Reversal
Current Algorand technical analysis reveals a compelling setup for upside momentum. The RSI at 42.39 has recovered from oversold conditions below 37, indicating selling pressure is diminishing. More importantly, the MACD histogram shows a positive reading of 0.0019, signaling the first bullish momentum shift in recent sessions.

The Bollinger Bands positioning tells a key story - with ALGO trading at 0.55 position between the bands, there's significant room for expansion toward the upper band at $0.13. The price is currently testing the middle band (20-day SMA) at $0.12, which has acted as dynamic support.

Volume analysis shows $2.2 million in 24-hour trading, which while modest, provides sufficient liquidity for a meaningful breakout. The daily ATR of $0.01 suggests low volatility, often a precursor to larger moves.

Algorand Price Targets: Bull and Bear Scenarios
Bullish Case for ALGO
The primary ALGO price target sits at $0.14, representing the immediate resistance level where previous rallies have stalled. A break above this level opens the path to $0.16, which aligns with the upper range of our Algorand forecast.

For this bullish scenario to unfold, we need to see RSI push above 50 (currently 42.39) and sustained MACD histogram positivity. The 50-day moving average at $0.13 must be reclaimed, acting as support rather than resistance.

A successful break of $0.14 could trigger momentum toward the $0.19 strong resistance level, though this would require broader crypto market cooperation and renewed institutional interest in Algorand's ecosystem developments.

Bearish Risk for Algorand
The downside risk centers on the $0.11 support level, which represents both immediate technical support and the 52-week low. A break below this critical level could trigger further selling toward $0.10, representing a -17% decline from current levels.

Key bearish catalysts to monitor include RSI falling back below 40, MACD histogram turning negative, and failure to hold above the lower Bollinger Band at $0.11. The 200-day moving average at $0.20 remains well above current price action, indicating the longer-term trend remains challenged.

Should You Buy ALGO Now? Entry Strategy
Based on current Algorand technical analysis, the risk-reward setup favors a cautious bullish approach. The optimal entry strategy involves scaling into positions:

Primary Entry Zone: $0.115-$0.12 (current range)
Stop Loss: $0.109 (below 52-week low)
Initial Target: $0.14 (+17% upside potential)
Risk-Reward Ratio: 2.8:1

For conservative investors wondering buy or sell ALGO, dollar-cost averaging into small positions makes sense given the proximity to yearly lows. However, position sizing should remain modest until the $0.14 resistance is definitively broken with volume confirmation.

Risk Management: Limit positions to 1-2% of portfolio allocation given ALGO's distance from its 200-day moving average and the broader uncertainty in altcoin markets.

ALGO Price Prediction Conclusion
Our ALGO price prediction maintains a cautiously bullish outlook with a target of $0.14 within the next 7 days, representing 17% upside potential. This forecast carries medium confidence based on improving technical momentum indicators and oversold conditions presenting a mean reversion opportunity.

The key indicators to watch for confirmation include RSI sustaining above 45, MACD histogram remaining positive, and daily closes above $0.125. Invalidation signals would be a break below $0.11 support or RSI falling back into oversold territory below 35.

Timeline for this Algorand forecast extends through the first week of January 2026, with the $0.14 breakout serving as the catalyst for potential extension toward $0.16. However, failure to achieve this target within 10 days would likely see ALGO consolidating in the $0.11-$0.13 range through the remainder of January.

Image source: Shutterstock

algo price analysis
algo price prediction
2025-12-30 16:06 3mo ago
2025-12-30 09:58 3mo ago
Bitmine Immersion's $13.2B Crypto War Chest Aligns with Tom Lee's Ethereum Supercycle Outlook cryptonews
ETH
flash news

Bitmine Stakes $1B In ETH Within 48 Hours

BitMine Immersion Technologies moved more than $1 billion worth of Ether into staking contracts in under 48 hours, with the activity tracked by Lookonchain, according

Ethereum News

Ethereum Validators Line Up as Staking Surges Beyond Exits

TL;DR Validator queues: More than 745,000 ETH is lined up to stake compared to just 360,000 ETH in exits, marking the first time in six

flash news

Bitmine Faces $3.5B Hit as Ethereum Stays Under $3K

Bitmine is carrying an unrealized loss of roughly $3.5 billion on its Ethereum position, according to on-chain data from CryptoQuant. The loss is a direct

Ethereum News

BitMine Expands ETH Holdings With $88M Purchase

TL;DR BitMine expanded its ETH treasury after watchers flagged about $88 million in flows; a filing said it bought 98,852 ETH last week. Observers tied

Companies

BitMine Scoops Up $300M in Ether, Treasury Surpasses 4M ETH

TL;DR ETH Milestone: BitMine added 98,852 ETH, lifting its holdings to 4,066,062 tokens worth over $12 billion, equal to 3.37% of the ETH supply. Market

flash news

Is Bitcoin Too Cheap? Tom Lee Suggests What’s Coming Next

Tom Lee, CIO of Fundstrat Capital, has anticipated an imminent Bitcoin rebound after labeling the asset as “extremely oversold.” Lee relied on Julien Bittel’s analysis
2025-12-30 16:06 3mo ago
2025-12-30 09:58 3mo ago
Lighter DEX Introduces Native LIT Token as Part of Ecosystem Expansion cryptonews
LIT
Lighter, a perp DEX, unveiled its LIT token, outlining its tokenomics with a 50–50 allocation between the ecosystem and team/investors
Then, launched the LIT/USDC pair for live trading, marking its expansion beyond perpetual markets.

Lighter, a decentralized perpetual exchange and DeFi infrastructure platform, has unveiled its native token for its crypto ecosystem, named Light Infrastructure Token (LIT). They confirmed it through their X handle by this morning in a thread post,  describing its token allocation, structure, and utilities. Then, within a few hours, the lighter activated the LIT/USDC trading pair, and the token was live on the platform after the announcement.

Where this Lighter is built on Ethereum Layer 2 using Zero-knowledge rollup technology, in the post, they mentioned in the thread post that the earnings generated by their main DEX product, as well as future products and services, can be tracked openly by anyone in real time on chain and will be divided between growth and buybacks depending on market circumstances.

We are announcing the Lighter Infrastructure Token (LIT)! Lighter is building infrastructure for the future of finance and the native token is key to aligning incentives. In this thread, we will describe the structure of the token, broader vision, and roadmap of use cases.

— Lighter (@Lighter_xyz) December 30, 2025
Token Allocation and LIT Use Cases
When it comes to token allocation, the total supply of the LIT token is 1 billion. With that,  the Lighter clarified that half of the percentage is kept for the ecosystem. Then, the other 50% is reserved for the team/investors, in that 26% is vested in the team and 24% allocated to investors.  

Regarding the ecosystem portion, the 2025 points season programs produced 12.5 million points, which will be distributed immediately through an airdrop. This equates to 25% of the entire token supply. The remaining 25% will be preserved for future reward schemes, with a tiny portion going toward partnerships and ecosystem growth.

With that, they have added that the LIT tokens are not only used for governance, but also have other use cases. The Lighter platform offers trading excursion and data verification services designed in different tiers, which require staking of the LIT tokens to use the features to their full potential. Also, LIT is to pay fees for all platform activities.

Lighter Introduces New Trading Pair
Then, shortly after the LIT token announcement, Lighter announced its LIT/USDC trading pair this morning through its X handle and Discord channel. As the LIT  is live now and available for trading, it is drawing attention from crypto circles.

New listing: $LIT is live! pic.twitter.com/grbcGUMkI2

— Lighter (@Lighter_xyz) December 30, 2025
​Previously, on October 2, Lighter introduced its public mainnet after 8 months of private beta as the largest perpetual exchange. Many reports compare Hyperliquid and Aster, because in this scene of perps DEX space, already those two are operating as benchmarks, with Lighter entering now, within two months of mainnet launch, it has grown beyond perpetuals and unveiled its spot trading pair.  

​Highlighted Crypto News Today:

‌Strategy Keeps BTC Interest Afloat After Bitcoin Price Loses Momentum
2025-12-30 16:06 3mo ago
2025-12-30 09:59 3mo ago
Cardano vs. Bitcoin Cash: Ultimate Dominance Fight Is On cryptonews
ADA BCH
Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Cardano (ADA) may soon overtake Bitcoin Cash (BCH) as the 10th-largest cryptocurrency by market capitalization. On the daily chart, BCH has experienced an uptrend as the ADA price stalls amid mixed sentiment on the broader crypto market.

BCH competes with ADA for dominanceAccording to CoinMarketCap data, ADA is currently trading for $0.35, down 3.4% over the past 24 hours. Despite the daily price decline, ADA remains the 10th-biggest cryptocurrency, with a market capitalization of $12.66 billion.

Trailing behind ADA on the market cap hierarchy is Bitcoin Cash. With a market cap of $12.07 billion, BCH is currently the 11th-largest cryptocurrency. 

As the BCH market cap climbs, it breaches the gap with ADA by only about $66 million. This puts Cardano's top 10 spot at risk of being overtaken by BCH.

Meanwhile, within the past 24 hours, the BCH price increased by 0.6%, setting the coin at $601.6. This daily spike pushed BCH higher by 4% on the weekly time frame.

It is also worth noting that BCH has shown a remarkable performance over the past few months. In late November, BCH outperformed Bitcoin (BTC) in a day by jumping 8%. The positive outlook for BCH was a response to anticipations of a broader market reversal. 

With the BCH momentum rising, it could easily displace ADA, unless the latter sees a strong catalyst.

You Might Also Like

Will Cardano relinquish position to Bitcoin Cash?Although BCH is close behind, Cardano (ADA) remains a top contender on the crypto market. Accordingly, ADA may fight harder to remain on top, supported by some strong ecosystem developments.

For instance, a broader market rebound, progress in Midnight sidechain or DeFi growth could spur an ADA rally. Already, Midnight's native token, NIGHT, is eyeing the $0.10 mark. If NIGHT successfully hits this milestone, it could force a fast rank jump across major crypto market tops.

Additionally, year-end profit-taking on BCH could reverse the pressure on Cardano. Also note that ADA recently outperformed the rest of the major cryptocurrencies after its price surged by 7%.

Therefore, thin liquidity and position resetting into the Cardano have amplified moves around obvious technical levels. ADA investors now anticipate an end-of-year breakout.

Furthermore, Cardano's research-driven upgrades could regain traction in 2026, positioning ADA for higher prices.
2025-12-30 16:06 3mo ago
2025-12-30 10:00 3mo ago
One Last Hurdle Before Zcash Price Rallies Above $1,000? Here Is What The Charts Say cryptonews
ZEC
Zcash (ZEC) has been one of the few clean trend performers this year. The token is flat in the past 24 hours but still up almost 30% in seven days, extending its three-month move to nearly 570%. Now, the Zcash price sits against a bullish channel resistance that has capped every breakout attempt since early December.

One more push could be different. The structure is bullish, but one confirmation still stands between Zcash and its long-delayed attempt at $1,000.

Sponsored

Zcash Tests Bullish Channel — But One Confirmation Is NeededZcash is trading near the upper boundary of a rising channel. This channel has guided the uptrend since early December. Price has respected every retest, but buyers need a clean daily close above the upper trendline to open higher targets.

The main missing piece is capital flow confirmation.

Chaikin Money Flow (CMF), which tracks buying strength using price and volume, has trended slightly lower while price trended higher between December 27 and 31. That is a mild bearish divergence. It tells us capital inflow slowed down even as prices pushed higher, which delays conviction.

Zcash Pattern: TradingViewWant more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

The CMF, which is still comfortably above the zero line, needs to break above its trendline and make a higher high above 0.13 to confirm strength. If that happens, the Zcash price could follow through. A return of big buyers would likely be the trigger for that CMF breakout. But the next metric shows that those buyers might already be returning.

Sponsored

Whales Accumulate, Smart Money Adds ExposureSpot behavior is showing the first hints of support.

On the Solana Chain, Zcash whales increased balances by 3.53% in 24 hours, lifting their total to 10,587 ZEC. That is an addition of roughly 361 ZEC, equal to about $191,000 at the spot price.

Mega whales (top 100 wallets) also added 1%, taking their stash to 36,323 ZEC. That is also around 360 ZEC added, equal to another $190,000. Whales are not buying aggressively yet, but they are no longer absent. This hints that accumulation is restarting.

Whales Start Adding: NansenSponsored

Exchange balances support that view. ZEC supply on exchanges slipped slightly in the past day, signaling ongoing accumulation and reduced sell-side liquidity. It is small, but direction matters here.

The derivatives market agrees. Smart money positioning (non-retail accounts) shows a 22.48% increase in net long exposure. The biggest derivatives players remain net short overall, but their long positions increased faster than shorts (up 745%), which is rare this close to resistance unless a breakout is expected.

Long Positions Increase: NansenThis matters because whales often drive CMF higher. If whale inflows continue, the CMF trendline could break, which would confirm the channel breakout.

Sponsored

Zcash Price Target Of $1,000 Still Possible?ZEC trades below the first trigger at $546. A close above that opens the door to $594. That is the real battle for the Zcash price.

If $594 breaks with CMF confirmation, pattern projection from the rising channel gives an 84% upside target, placing Zcash near $831 and beyond. That is the springboard. From that point, a secondary Fibonacci extension path aligns with a move toward $1,007 as the next major target, approximately 89% from the current level.

Zcash Price Analysis: TradingViewInvalidation levels matter too. Losing $509 weakens momentum, whereas losing $479 flips the structure to neutral. If Zcash loses $437, it breaks the channel completely and cancels the bullish case.

As long as ZEC stays above $479, the channel remains valid. Above $594 with CMF support, the breakout is live.
2025-12-30 16:06 3mo ago
2025-12-30 10:00 3mo ago
HYPE steadies as LIT's post-airdrop sell-off deepens: What happens next? cryptonews
LIT
Journalist

Posted: December 30, 2025

The cut-throat competition in the perpetual decentralized exchanges, popularly known as Perp DEXes, has stalled the market leader, Hyperliquid. 

Rivals such as Binance-backed Aster saw significant traction in H2 2025. But most analysts considered Lighter the real threat to Hyperliquid, citing several features, including privacy.  

However, ahead of the Lighter [LIT] token debut and airdrop for early users, Messari research analyst Sam has downplayed its threat.

In fact, Sam projected that HYPE could outperform LIT in the mid-term, adding that, 

“HYPE will reprice back to the ‘endgame perp DEX.’ HYPE investors won’t have to worry about fee compression for the foreseeable future.”

For Sam, Lighter’s perp volume was ‘falling off a cliff’ because the initial farming period that attracted most traders from Hyperliquid is almost over. 

Source: DeFiLlama

Will Hyperliquid revenue recover?
In H2, Hyperliquid’s perpetual volume dropped significantly amid rising competition and lower trading activity in Q4 2025. It fell from $396 billion to $165 billion — That’s about 60% decline in traction.  

Source: DeFiLlama

The cool-off also compressed the generated fees and revenues used to drive HYPE buybacks.

In fact, average weekly revenue dropped from $20 million in Q3 to as low as $7 million in late December -A whopping 65% revenue shortfall. 

With ongoing monthly unlocks alongside the low pace of token buybacks, bears had a field day with HYPE. However, Sam believes a reversal could be likely if Lighter farmers return to Hyperliquid. 

HYPE vs. LIT price action
Meanwhile, Lighter officially announced the LIT token, noting that 25% of the total supply of 1 billion tokens will be immediately airdropped to early users.

The rest of the tokenomics mirrored HYPE, including a 1-year vesting period for teams and utilizing revenue for buybacks. 

“Revenues from our core DEX product will be allocated between growth and buybacks depending on market conditions.” 

The token’s TGE listing price was $3.3, but it has dropped to $2.7, representing a 21% decline in the past seven days of trading. It experienced a 16% decline over the past 24 hours. 

On the other hand, HYPE was up over 2% in the 24 hours and could flip short-term bullish if it clears the recent peak at $26.4. The next roadblock and overheat resistance would be $27. 

Source: HYPE/USDT, TradingView

Final Thoughts 

Lighter perp volume has dropped following the end of airdrop farming, and the LIT price also declined. 
HYPE experienced a short-term bounce, but it was unclear whether the recovery would extend.  
2025-12-30 16:06 3mo ago
2025-12-30 10:00 3mo ago
Breaking: Grayscale Files S-1 For First Bittensor (TAO) ETF With U.S. SEC cryptonews
TAO
Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017,
aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy,
our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a
rigorous Review Methodology when evaluating exchanges and tools. From emerging
blockchain projects and coin launches to industry events and technical developments, we cover
all facets of the digital asset space with unwavering commitment to timely, relevant information.

Crypto ETF issuer Grayscale is seeking to convert its GTAO fund into the first Bittensor ETF, a move that will further widen its crypto ETF offerings. The TAO price has climbed above $220 on the back of Grayscale’s filing, erasing its intraday losses in the process.

Grayscale Files S-1 For Bittensor ETF With SEC
An SEC filing shows that Grayscale has filed a Form S-1 to convert its Bittensor Trust into an ETF, which could potentially become the first ETF to provide institutional investors with 100% spot exposure to the AI token, TAO. The asset manager also revealed that it plans to list the fund on the NYSE Arca under the ticker ‘GTAO.’

The filing follows Bittensor network’s first halving event, which took place on December 14. The TAO halving cut daily token issuance from 7,200 to 3,600, a move expected to boost the price of the top AI token moving forward.

The Bittensor ETF will hold the AI crypto coin, including tokens earned from staking, as the asset manager plans to implement staking. The filing lists Bank of New York Mellon as the transfer agent. Furthermore, top crypto exchange Coinbase is the Trust’s prime broker, while its custody arm is the custodian, with BitGo acting as an additional custodian.

Grayscale also noted in the filing that NYSE Arca has received regulatory approval permitting the Trust to conduct creations and redemptions of Shares via in-kind transactions with Authorized Participants in exchange for TAO. As such, the Trust currently conducts creations and redemptions of Shares pursuant to In-Kind Orders, which is likely to continue once it converts it into an ETF.

GTAO Already Trading Publicly On The OTCQX
This Bittensor ETF filing comes just weeks after the Grayscale Bittensor Trust began trading on the OTCQX under the ticker symbol “GTAO,” following the effectiveness of its Form 10 filing with the SEC. The asset manager earlier mentioned back then how the effectiveness of the registration statement would bring it one step closer to becoming an ETP.

Notably, as an SEC reporting company, it has a holding period reduced to six months, which takes effect after the Trust has been a reporting company for at least 90 days and has satisfied the other requirements under Rule 144 of the Securities Act. Based on this rule, the registration statement for the Grayscale Bittensor ETF could become effective next year.

Grayscale already offers several crypto ETFs that provide exposure to crypto assets such as Bitcoin, Ethereum, XRP, Dogecoin, Solana, and Chainlink. As CoinGape reported, it also recently updated the S-1 for its Avalanche ETF, which is among the new crypto ETFs it plans to launch soon.

The TAO price climbed above $220 on the back of Grayscale’s S-1 filing for a Bittensor ETF. The top AI crypto coin is currently trading at around $222, up from an intraday low of around $217.

Source: Yahoo Finance; TAO Daily Chart
2025-12-30 16:06 3mo ago
2025-12-30 10:01 3mo ago
Cypherpunk doubles down on Zcash as treasury hits 290,062 ZEC cryptonews
ZEC
Cypherpunk Technologies Inc. has further expanded its Zcash holdings, pushing its corporate treasury to over 290,000 ZEC. The company shared the announcement on December 30, 2025. According to details, the fresh Zcash buy highlights the company's ongoing commitment to accumulating the privacy coin. It comes as institutional interest in financial anonymity tools takes root.
2025-12-30 16:06 3mo ago
2025-12-30 10:06 3mo ago
Grayscale files initial S-1 for Bittensor ETF cryptonews
TAO
Grayscale’s Bittensor Trust allows investors to gain exposure to TAO without holding the tokens directly.

Key Takeaways

Grayscale Investments filed an S-1 registration statement with the SEC for Grayscale Bittensor Trust ETF.
The Trust holds TAO, a digital asset from the Bittensor Network.

Leading asset manager Grayscale Investments has filed an S-1 registration with the SEC to convert its Bittensor Trust into an exchange-traded fund, according to a Tuesday announcement. If approved, it would become the first TAO ETP in the US.

Today we filed the initial S-1 for Grayscale Bittensor Trust (ticker: $GTAO) with the @SECGov

This milestone is the next step in converting $GTAO to an ETP, which would make it the first $TAO ETP in the U.S. and another first for Grayscale.

Read the S-1:… pic.twitter.com/2qg6AgqYOg

— Grayscale (@Grayscale) December 30, 2025

The proposed fund would broaden Grayscale’s crypto ETF lineup, which already includes major assets such as Bitcoin, Ethereum, Solana, XRP, Dogecoin, and Chainlink. The firm is also waiting for final approval to launch additional funds tied to other leading crypto assets.

Grayscale rolled out the Grayscale Bittensor Trust last August alongside its Sui Trust. The firm expressed confidence that Bittensor would become a key driver of decentralized AI development.

Grayscale intends to list the product on NYSE Arca under the GTAO ticker and rename it as an ETF-style vehicle. The trust seeks to mirror TAO’s value, but staking is prohibited unless future conditions are met.

TAO edged up on the news, moving from $219 to $222 in 30 minutes, according to CoinGecko.

Disclaimer
2025-12-30 16:06 3mo ago
2025-12-30 10:16 3mo ago
Aave Commands 59% of DeFi Lending Market as Bankification Era Begins cryptonews
AAVE
TLDR:

Aave controls 59% of DeFi lending market and generates more revenue than next five competitors
Protocol generated $885 million in fees during 2025 from real economic activity, not emissions
Aave App offers 5%+ yields with fiat deposits, mimicking neobank experience for retail users
Survey data reveals 74% of institutional investors planning DeFi entry within two-year timeframe

Aave controls 59% of the decentralized finance lending market and processes 61% of all active loans.The protocol generated $885 million in fees during 2025 alone. Industry observers point to these metrics as evidence of Aave’s readiness for mainstream financial services. 

The platform now produces more revenue than its next five competitors combined. This market position sets the stage for what crypto analyst Jonaso calls “bankification” of DeFi protocols.

Market Dominance and Revenue Generation
Aave commands the largest share of total value locked among DeFi lending platforms. The protocol processes the majority of active lending transactions across the ecosystem. This concentration of activity creates deeper liquidity pools than competing platforms can match.

Revenue data from 2025 places Aave ahead of established competitors by a considerable margin. The protocol captured 52% of all lending protocol fees generated this year. 

These figures represent actual user payments rather than token emissions or inflationary rewards.

The scale of operations now mirrors traditional financial institutions in key metrics. According to analyst Jonaso on social platform X, this positioning makes Aave the natural candidate to bridge DeFi and conventional banking. 

Aave is the DeFi Protocol with the highest level of bankification

If you look at key numbers like TVL, active loans, and revenue, @aave clearly dominates the DeFi lending market.

– 59% of the DeFi lending market
– 61% of all active loans
– $885M in fees generated this year
-… https://t.co/9Xi1tOTUKi pic.twitter.com/asALXg6f2m

— Jonaso (@Jonasoeth) December 30, 2025

Traditional finance metrics suggest the platform operates at bank-level transaction volumes. This capacity enables the next phase of product development.

Aave App and the Bankification Strategy
DeFi markets are shifting away from yield farming based on token emissions. Protocols now focus on generating sustainable revenue from real economic activity. 

Real-world assets and stablecoin infrastructure dominate development roadmaps for 2025 and 2026. Survey data indicates 74% of institutional investors plan to enter DeFi within two years.

The Aave App represents a departure from complex protocol interfaces. Users can access savings accounts offering over 5% annual yields through mobile devices. 

Fiat currency deposits integrate directly with the application. The design mimics neobank experiences familiar to mainstream consumers.

This strategy creates a self-reinforcing cycle of growth and stability. User deposits increase liquidity depth, which reduces borrowing costs for institutional clients. 

Lower costs attract more institutional demand, stabilizing yields for retail savers. Jonaso describes the application as a “Trojan horse for DeFi adoption” that could trigger a new market cycle. Early DeFi protocols like Uniswap and Lido established the foundation. 

Newer platforms including Ethena, Pendle, and Altura now join Aave in pushing toward mainstream acceptance. The focus centers on passive savings products and sustainable yield generation.
2025-12-30 16:06 3mo ago
2025-12-30 10:16 3mo ago
Solana Draws $2.93M in ETF Inflows as Traders Watch $118 Make-or-Break Zone cryptonews
SOL
SOL sees inflows amid cautious ETF moves, approaching a make-or-break test at $118 with liquidity zones in focus.
2025-12-30 16:06 3mo ago
2025-12-30 10:22 3mo ago
Lighter Launches LIT Token With a Clear Bet on Ecosystem Growth cryptonews
LIT
When a decentralized exchange launches a native token, the real story is not the ticker or the opening price. It’s how incentives are structured and who actually benefits over time. With the launch of its Lighter Infrastructure Token, LIT, Lighter is making a deliberate statement about long term alignment, transparency, and control.

What Is the LIT Token Meant to Do?According to the team, LIT token is designed to align incentives across users, builders, and infrastructure participants. It is not positioned as a speculative add on but as the core economic layer that underpins everything built on Lighter’s infrastructure.

All value generated by Lighter’s current products and any future services is intended to accrue directly to LIT holders. Revenues from the decentralized exchange and upcoming infrastructure offerings will be fully transparent and trackable onchain, with funds directed toward growth initiatives and token buybacks. In short, usage drives value, and value flows back to the token.

Token Allocation Puts the Ecosystem FirstLighter’s tokenomics lean heavily toward community and ecosystem development. Half of the total LIT token supply is allocated to the ecosystem, signaling a long term commitment rather than a short term liquidity play.

Out of this 50 percent allocation, 25 percent of the fully diluted value will be distributed immediately through an airdrop to participants from the first two points seasons of 2025. The remaining ecosystem allocation is reserved for future incentive programs and strategic partnerships, ensuring sustained engagement and expansion over time.

The remaining supply is split between the team and investors. The team will receive 26 percent, while investors are allocated 24 percent. Both allocations are subject to a one year lock followed by a three year linear vesting schedule, a structure that reduces early sell pressure and reinforces long term alignment.

Staking, Infrastructure, and Progressive DecentralizationBeyond simple ownership, LIT plays a functional role in how Lighter’s infrastructure operates. The platform’s systems for financial transactions and fairness verification will be tiered based on LIT token staking. Higher staking levels unlock deeper infrastructure access, while decentralization of these functions will increase progressively over time.

Notably, Lighter emphasized that it is building in the United States and that the token is issued directly from its C Corp entity, which will continue to operate the protocol at cost. This hybrid structure aims to combine regulatory clarity with onchain transparency, a balance many crypto projects still struggle to achieve.

Market Debut and Early Price ActionLighter launched the LIT USDC trading pair early Tuesday morning. As of writing, LIT token was trading around $2.72 on Lighter, down from a pre market price of roughly $3.25. While the initial pullback reflects typical post launch volatility, liquidity and participation remained strong during the early trading window.

Price aside, the launch marked an important milestone in Lighter’s broader growth trajectory, shifting the platform from pure product expansion to a fully tokenized ecosystem model.

Lighter’s Rapid Rise in the Perps MarketLighter is not launching LIT token from a position of weakness. Since going live on public mainnet in October, the exchange has emerged as one of the largest players in the decentralized perpetuals space.

In November alone, Lighter recorded $292.5 billion in trading volume, outpacing Aster at $259.2 billion and Hyperliquid at $243.6 million, based on data from The Block. That level of volume places Lighter firmly among the top tier of onchain derivatives venues.

Momentum has carried into funding and product expansion as well. In November, Lighter raised $68 million at a $1.5 billion valuation in a round led by Founders Fund and Ribbit Capital. In early December, the platform expanded beyond perpetuals with the rollout of spot trading, broadening its appeal and revenue base.

What this really means is that LIT is not just a governance token or a reward mechanism. It is the economic backbone of a rapidly scaling exchange and infrastructure stack. With half the supply committed to ecosystem growth, strict vesting for insiders, transparent revenue flows, and a clear staking utility, Lighter is positioning LIT as a long term asset tied directly to platform usage.

As the decentralized derivatives market continues to mature, Lighter’s approach suggests a focus on durability over hype. Whether LIT ultimately succeeds will depend on continued volume growth, effective incentive design, and execution, but structurally, the foundation is now firmly in place.
2025-12-30 16:06 3mo ago
2025-12-30 10:30 3mo ago
7-Period Fractal Trend Says Dogecoin Price Is Headed To $10 cryptonews
DOGE
Every recent Dogecoin recovery attempt has met overhead pressure, and this has kept the price action capped below $0.15. A look at the price chart shows the recent price action is part of a broader downtrend that has been playing out for the past three months, and the meme coin is about to end the year in red. However, a longer-term technical analysis suggests that the calm phase could be part of a much larger setup.

According to the analysis, Dogecoin may be following a recurring fractal rhythm tied to the number seven. This repeating timing structure points to a much larger upside target for the meme coin over the coming years, stretching as high as $10.

A Recurring Seven Rhythm Across Markets
The foundation of the technical analysis is based on the idea that different assets tend to pivot in repeating time-based fractals of seven. This phenomenon has been observed in markets ranging from gold to the S&P 500, where important tops and bottoms often align around similar intervals of seven. Bitcoin’s historical behavior is highlighted as a key reference point, particularly the 2021 double top, which formed seven months apart and is an important transition in its cycle.

This same rhythm becomes apparent when mapped onto Dogecoin. Particularly, Dogecoin topped roughly seven months before Bitcoin during the last cycle, then lagged Bitcoin by another seven months during subsequent phases. Even Dogecoin’s rise from the start of its macro Elliott Wave 1 is framed within this same seven-month timing structure, showing that its major turning points have been surprisingly consistent.

Source: Chart from Tradingview
The chart shared alongside the analysis shows a sequence of price expansions and consolidations that unfold in roughly seven-month blocks since July 2023, each characterized by either uptrends or downtrends. 

Now that the traditional four-year crypto cycle shows signs of losing its influence, the analyst proposed that a transition may be happening toward a longer, seven-year rhythm from macro bottom to macro top. Under this lens, Dogecoin’s current position is more like a mid-cycle consolidation.

How The Fractal Points To A $10 Target
Using the same fractal spacing projected forward, the analysis extends Dogecoin’s long-term trajectory into the next major cycle window. The green projection box on the chart illustrates a future expansion phase that mirrors earlier rallies but on a larger scale, consistent with the idea of a bigger seven-year cycle. If Dogecoin continues to respect the same timing and channel structure, the projected upside region converges between the $7 to $10 zone over the next few years.

The first move in this case would be a return to bullish momentum over the coming months, and then a reclaim above the resistance trendline just below $0.4.

DOGE trading at $0.12 on the 1D chart | Source: DOGEUSDT on Tradingview.com
Featured image from Getty Images, chart from Tradingview.com
2025-12-30 16:06 3mo ago
2025-12-30 10:31 3mo ago
Grayscale files for spot Bittensor ETF following network's first halving event cryptonews
TAO
Grayscale seeks to convert its Bittensor Trust into an ETF, just weeks after the network's native token underwent its first halving event.
2025-12-30 16:06 3mo ago
2025-12-30 10:34 3mo ago
Half-Trillion Shiba Inu (SHIB) Withdrawal Stuns Major US Exchange Coinbase: What's Going On? cryptonews
SHIB
Tue, 30/12/2025 - 15:34

Big Shiba Inu position worth $3.47 million just left Coinbase through its Prime infrastructure, and the way it exited makes the move harder to dismiss as a simple coincidence.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

As revealed by Arkham's data, a total of 485,106,817,819 SHIB was transferred from a Coinbase Prime hot wallet to one untagged address over just two days. This was not a single, big-deal transaction, as the accumulation was broken into three smaller parts. Once the transfers were done, the receiving wallet was left holding 485.1 billion SHIB as its main asset, with a valuation just above $3.47 million.

There are only a few realistic options here. One is that the owner plans to keep Shiba Inu (SHIB) off-exchange, which would remove the immediate sell-side supply from Coinbase and let them bet on later repricing. Another is that the wallet acts as an operational hub, a pause before distribution to other venues, liquidity routes or structured positions.

Source: ArkhamThe withdrawal happened during a period when SHIB was trading closer to weekly lows around the $0.0000072 zone, rather than during a price spike. That is basically the line where dips get bought by optimists and sold into by tired holders, so seeing coins pulled off-exchange here reads like someone accepting short-term heat for a longer hold.

HOT Stories

Shiba Inu (SHIB) price is keyPrice-wise, if SHIB holds above the $0.0000071 to $0.0000072 zone, the next upside targets will be $0.0000074 first and then the $0.0000078 area, mostly because that is where recent weekly rejection tends to cluster. 

Should SHIB lose that band and print lower weekly closes, the market will start hunting for the next demand pocket around $0.0000068.

You Might Also Like

The next phase will be visible soon. If the wallet sits idle, the market story will start to shift toward accumulation and a longer-term strategy. If the SHIB starts moving in pieces again, the story will switch to staging and execution. Either way, the numbers speak for themselves.

Related articles
2025-12-30 16:06 3mo ago
2025-12-30 10:34 3mo ago
Analyst Benjamin Cowen Calls Bitcoin Bear Market, Reveals 2026 BTC Prediction cryptonews
BTC
A widely followed crypto analyst and trader says Bitcoin (BTC) is officially in a bear market.

With BTC currently trading for $87,138, down 4% in the last month, crypto trader Benjamin Cowen tells his 970,000 YouTube subscribers that BTC is likely to fall further in 2026.

“What I think makes the most amount of sense is for Bitcoin to drop into the in sort of like early 2026, rally back up to the bull market support band and then back down to the 200 week moving average and then consolidate there. Maybe you go a little bit lower in October because a lot of the bare markets do last about a year and then hopefully we can get back on track. That’s what I think makes the most amount of sense right now.

You can see that even back then Bitcoin did have a breakout after about 6 months. Yes, we had the pandemic induced recession, but I mean we we came right out of it as well. That’s where I am with the markets.”

According to the analyst, BTC currently has similar market conditions to major bear markets of the past. However, Cowen advises against panic.

“When I look at this market cycle, when I look at the current market conditions, do I say it’s a bear market like 2022, 2018, 2014? Technically, if the foyer cycle remains intact, we can’t ignore it. But because we topped on apathy rather than euphoria, I have to defer to the 2019 bear because this is the only current bare market that we’re actually below, right? I mean, if you look at all the others, we’re still well above them. And there was no major panic, right? No major panic.”

Generated Image: Midjourney
2025-12-30 16:06 3mo ago
2025-12-30 10:37 3mo ago
What's Next for Solana in 2026? 5 SOL Predictions for the New Year cryptonews
SOL
This Week’s Market Overview
Season’s beatings! SOL (SOL) briefly lost its $120 support but countered with a weak bounce, and still ended the week in the red.

And it was the same all around, with Bitcoin hitting $90,000 before slipping below $88,000 in no time as post-Christmas pain continues.

Source: Ted Pillows

Solana Ecosystem News
What about the top Solana ecosystem tokens?

The trenches are showing signs of life again, as the ecosystem’s trading volume edged up 11% to $12 billion. Yet the market cap is down by 3% to $173 billion.

Powered by Kalshi, Phantom's highly anticipated prediction markets are live for all eligible users.
The Solana-based stablecoin USX (USX) briefly depegged on DEXs when thin liquidity met heavy selling before Solstice Finance stepped in and restored dollar parity.

Solana's Performance This Week
The slide in the Solana ecosystem comes even as SOL products recorded institutional inflows for the second consecutive week, while the big boys — Bitcoin (BTC) and Ethereum (ETH) — were on the opposite end of the spectrum.

Source: SolanaFloor

L1 Ranking Update
Solana ends 2025 as the chain with the second-highest total value locked (TVL). BNB Smart Chain was hit hard among the top five, while Ethereum safely sits atop.

Source: DeFiLlama

Biggest Winners & Losers
Top Performers

The White Whale (WHITEWHALE): +1,202.37%
UNS TOKEN (UNS): +47.02%
NeuralAI (NEURAL): +39.14%

Biggest Losers

The Official 67 Coin (67): -48.65%
elizaOS (ELIZAOS): -27.49%
Humidifi (WET): -27.28%
Huma Finance (HUMA): -22.64%
LOOK (LOOK): -21.05%

Solana Predictions for 2026
2025 was big for Solana, as developers shipped and maxis sniped like there was no tomorrow. But with 2026 just around the corner, Solana is promising to go even faster.

Here are the top Solana 2026 predictions by experts. It appears that playtime is over for Solana as it goes after TradFi money big time.

1. Stablecoins to Skyrocket
The stablecoin market is projected to explode in 2026 after a groundbreaking year. For example, TradiFi giant Western Union is debuting its stablecoin on Solana next year.

Solana's co-founder predicts the stablecoin ecosystem will grow to a $1 trillion industry by 2026.

2. Internet Capital Markets
Solana's internet capital markets will be on a high in 2026, fueled by the Firedancer upgrade, which will boost network speed beyond 1 million transactions per second while finality drops below 150 milliseconds.

These enhancements will be a game-changer in DeFi and payments, among other spheres, making Solana a powerful base layer for exchanging value, raising capital, high-speed trading, and investing on the internet.

3. Institutional Momentum
It is a no-brainer that institutions will continue where they left off in 2025. Digital asset treasuries and ETFs will double down, with SOL revenue potentially outpacing Ethereum.

With the crypto CLARITY Act on course to pass in 2026, SOL could benefit from more ETF approvals and institutional liquidity.

Source: Arkham

Related Article: Solana 2025 Recap: SOL Goes Institutional After Outgrowing Meme Coin Phase

4. Prediction Markets to Power User Growth
Solana dominated all major blockchain networks by revenue in 2025. It is projected to repeat the same feat in 2026, driven by emerging trends such as prediction markets.

Additionally, this will bring more users to Solana, and its effect will be like SOL's run-up to an all-time high when President Trump launched his meme coin on the network.

Source: Mert Mumtaz

5. RWAs to Flourish
Solana's ecosystem, according to members of its brain trust, will lead in real-world asset (RWA) tokenization in 2026. Firms like Gemini and Fidelity are driving growth in tokenized treasuries and equities, with more bound to take a leaf from this playbook.

Source: Real World Asset Watchlist

What You Can Do Now

Audit your 2025 trades, and lock in a sharper strategy for 2026.
Track early 2026 narratives, and position before liquidity rotates.
Define profit targets and exits to protect capital, and avoid round trips.

That’s it, folks. Signing off. Happy 2026!

This article contains links to third-party websites or other content for information purposes only (“Third-Party Sites”). The Third-Party Sites are not under the control of CoinMarketCap, and CoinMarketCap is not responsible for the content of any Third-Party Site, including without limitation any link contained in a Third-Party Site, or any changes or updates to a Third-Party Site. CoinMarketCap is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement, approval or recommendation by CoinMarketCap of the site or any association with its operators. This article is intended to be used and must be used for informational purposes only. It is important to do your own research and analysis before making any material decisions related to any of the products or services described. This article is not intended as, and shall not be construed as, financial advice. The views and opinions expressed in this article are the author’s [company’s] own and do not necessarily reflect those of CoinMarketCap.
2025-12-30 16:06 3mo ago
2025-12-30 10:41 3mo ago
Bitcoin (BTC) Price Over $150,000, When? Haseeb Qureshi Has Answer cryptonews
BTC
Tue, 30/12/2025 - 15:41

Haseeb Qureshi, seasoned crypto VC and managing partner of Dragonfly Capital, shares his bold predictions for 2026.

Cover image via u.today

Bitcoin (BTC), the largest cryptocurrency, will rally by 67% and hit the $150,000 milestone in 2026. The stablecoin segment will also be rocketing together with the prediction markets scene, while AI usage outside tech will remain limited — that is how the top VC investor sees 2026 in Web3.

Bitcoin (BTC) price to surpass $150,000 in 2026, Haseeb Qureshi saysBitcoin (BTC), the biggest cryptocurrency asset, has all the chances to blast past $150,000 by the end of 2026 despite its dominance shrinking. Ethereum (ETH) and Solana (SOL) will expand its dominance in the segment of smart contract platforms for dApps while minor chains — even stablecoin-centric ones — will underperform, Haseeb Qureshi, managing partner in Web3 VC firm Dragonfly Capital, shares on X.

It’s that time again—as 2025 comes to a close, it’s time to drop 2026 predictions.

I think 2026 is going to surprise, both to the upside and to the downside. Organized by category:

Macro / Chains
* $BTC is > $150K by year-end, but BTC dominance decreases in 2026.
* Despite the…

— Haseeb >|< (@hosseeb) December 29, 2025 Also, we should expect more tech companies, including Fortune Top 100 heavyweights, to be releasing their own blockchain ventures. The segment will become concentrated, with a number of top-tier banks dominating here. In terms of infrastructure, more chains will leverage DoubleZero architecture.

In the segment of on-chain perps trading, maximum three venues will be dominating; the same will work for decentralized prediction markets. Almost all liquidity will be routed to Polymarket, Kalshi and Robinhood front-ends.

HOT Stories

The sphere of stablecoins will also grow at an impressive pace. The stablecoin supply will expand by 60% YoY, with USD-pegged stablecoins still controlling 99%+ of the market. USDT dominance will drop to 55%.

Changes in the political landscape in the U.S. might affect the audience of PolitFi meme coins and WLFI/USD1 ecosystems.

This segment set to rocket by 1,000%Qureshi indicated the segment that still can rally by over 10x from its current state — it is stablecoin-based cards. They will cement themselves as the main driver for retail stablecoin adoption, with Rain being an influential player.

The synergy between AI and Web3 will still remain controversial. While we are set to see more and more ultra-small teams (with less than 10 employees) delivering popular products, the full-scale agentic payments adoption will not happen next year.

Also, as security remains in focus for teams of all sizes, the number of big crypto hacks will drop compared to 2026, the VC veteran concluded.

Related articles
2025-12-30 16:06 3mo ago
2025-12-30 10:41 3mo ago
Ripple Goes All-In on Europe's Payment Infrastructure cryptonews
XRP
TL;DR

Ripple integrated its technology into the TAS Network Gateway, allowing European banks to access blockchain-based settlement without modifying their internal systems.
This places the company alongside the payment rails used for RTGS and cross-border euro transfers, operating as a parallel layer on top of existing banking infrastructure.
The model aims to improve interoperability, reduce delays and costs in international payments, and offer XRP as optional liquidity with no obligation to use it.

Ripple integrated its technology into the TAS Network Gateway and began operating within Europe’s core payment infrastructure. This new connection allows European banks to access blockchain-based settlement without making changes to their internal systems.

The integration places Ripple alongside the payment rails used by institutions for high-value transfers, real-time gross settlement, and cross-border euro payments. This technology does not replace existing banking systems. It operates as a parallel layer that connects traditional infrastructure with DLT-based settlement.

Ripple Enters Europe’s Financial System
The objective is to improve interoperability. Through TAS, banks can interact with blockchain technology without modifying their operational architecture. This minimizes technical issues and accelerates adoption within a regulated environment. At the same time, the design reflects the gradual approach that dominates the European banking system, where changes in settlement and liquidity progress incrementally.

Another core focus is addressing the structural problems of international payments. Current processes involve settlement delays, high costs, fragmented liquidity, and complex reconciliation between institutions. Ripple aims to shorten settlement times, simplify messaging, and reduce the number of intermediaries involved.

The operational flow includes traceability, auditing, and reporting within the payment process. These elements comply with European regulatory standards and ensure that transactions are fully visible to supervisors and relevant institutions.

Using XRP Will Not Be Mandatory
The use of XRP is not mandatory. Ripple offers the token as an optional liquidity tool through its on-demand liquidity model. When used, XRP acts as a bridge asset and reduces the need for pre-funded accounts in multiple currencies. If it is not used, the system continues to operate without exposure to the token.

Europe is moving toward the integration of DLT-based settlement systems and greater interoperability across infrastructures. Ripple is now embedded in the operational layer that will be used when these models move into full production
2025-12-30 16:06 3mo ago
2025-12-30 10:45 3mo ago
Metaplanet Bitcoin Stack Hits $3B After $450M Spree — Revenue Soars cryptonews
BTC
Metaplanet's total Bitcoin holdings reached 35,102 BTC (~$3B) after acquiring 4,279 BTC worth $451 million, while revenue from its BTC income generation surged to a record ¥8.58 billion (~$54 million) in 2025.
2025-12-30 16:06 3mo ago
2025-12-30 10:53 3mo ago
XRP Could Hit $24 If This Ultra Rare Golden Cross Is Confirmed on XRP vs. Bitcoin Chart cryptonews
BTC XRP
Tue, 30/12/2025 - 15:53

XRP is flashing an ultra-rare monthly golden cross against Bitcoin for the first time since 2018, a setup that could trigger a 1,200% relative run and map a $24 XRP case if BTC stays flat.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

XRP is showing some signs that traders pay attention to, like an ultra-rare golden cross on the monthly chart against Bitcoin, where the 23-month moving average crosses the 50-month one in a manner it did not for seven years, since 2018, as seen on TradingView chart.

The latest monthly close on the chart was around 0.00002116 BTC per XRP, and the "1,200% run versus Bitcoin" headline is math that puts the potential XRP/BTC target at 0.00027508 BTC per altcoin.

When you translate that into dollars, that is what makes the golden cross story stunning. With Bitcoin at $87,976 right now, XRP at 0.00002116 BTC implies about $1.86 per coin, and the 0.00027508 BTC target implies about $24.20 per coin if BTC stays flat.

HOT Stories

XRP/BTC by TradingViewThat target is not just some random number out of thin air. It is actually about 20% above the old XRP/BTC peak zone you can see on the chart near 0.00022865. So, the whole trade looks like a "breakout plus extension" instead of just a basic retest.

False alarm?If the cross is confirmed and the ratio starts moving closer to that 2018 ceiling, the market story is that XRP does not need Bitcoin to crash to win. It just needs sustained relative demand, and the upside math will become much more significant quickly.

You Might Also Like

Still, monthly signals are slow by design, so validation matters more than hype. If XRP/BTC can hold above the nearby resistance, it will probably build higher lows as volume expands. If it fails, the ratio will probably go back to the 0.00002 area, which would make the cross a false start. 

Related articles
2025-12-30 16:06 3mo ago
2025-12-30 11:00 3mo ago
How XRP's Utility Will Drive Price Appreciation In The New Year cryptonews
XRP
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Crypto pundit SMQKE has shared a document highlighting why XRP’s utility will drive price appreciation in the new year. This follows a debate sparked by another pundit, Lewis Jackson, who argued that the altcoin’s payment utility doesn’t translate to higher prices. 

In an X post, SMQKE shared a document that highlighted XRP’s utility through Ripple’s payment system. In line with this, he noted that this is further evidence that the token’s utility will drive future price appreciation. The pundit further remarked that XRP is designed to operate within the global payment infrastructure, a move that could widely boost its adoption. 

SMQKE also noted that Ripple integrates with existing systems to improve speed, cost, and settlement efficiency. As such, as financial institutions adopt the XRP Ledger (XRPL), the pundit stated that XRP will be used directly in payment flows. He then alluded to the document, which, from a payments perspective, he said, demonstrates how institutional settlement activity creates sustained demand for XRP. The pundit added that price appreciation is supported through real transaction flow. 

Source: Chart from SMQKE on X
The document noted that when Ripple processes a transaction, 0.00001 XRP is removed from circulation. As such, they expect the altcoin’s circulating supply to decline over time and its price to rise in the process due to a potential supply shock. On the other hand, Lewis Jackson claims that XRP is simply recycled whenever institutions use Ripple’s payment system for cross-border transactions. 

He declared that XRP’s utility is unlikely to drive higher prices, as these institutions, including banks, do not need to hold a significant amount of XRP to process transactions on Ripple’s payment system. This has sparked debate in the XRP community with another pundit, Apex Crypto, describing these statements as “dangerous junk” that could mislead people, especially new community members.

XRP Still At Risk Of Dropping Below $1
Crypto analyst Ali Martinez has warned that the XRP price is still at risk of dropping to as low as $0.80 amid debate over how the token’s utility will drive price appreciation. He outlined reasons why this massive price decline is a possibility, including that the XRP Ledger’s activity has cooled significantly. Martinez noted that daily active addresses have fallen to around 38,500, indicating fading participation and interest. 

Furthermore, the analyst stated that XRP whales have turned into sellers, offloading over 40 million coins in recent days. He added that if the selling pressure continues, the altcoin risks losing the $1.77 support level, with a breakdown opening the door to the next major support near $0.80. 

At the time of writing, the XRP price is trading at around $1.85, down over 2% in the last 24 hours, according to data from CoinMarketCap.

XRP trading at $1.87 on the 1D chart | Source: XRPUSDT on Tradingview.com
Featured image from Getty Images, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts.
Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.
2025-12-30 16:06 3mo ago
2025-12-30 11:04 3mo ago
Solana price displays accumulation near $120 as reversal signs emerge cryptonews
SOL
Solana price is showing early signs of accumulation near $124 as repeated support defenses and bullish reactions suggest a potential reversal if key volume levels are reclaimed.

Summary

$124 continues to act as key high-time-frame support.
Accumulation signs emerge with repeated bullish reactions.
POC reclaim needed to trigger a rally toward $167.

Solana (SOL) price is beginning to show constructive price behavior after an extended period of downside pressure. Recent price action suggests that accumulation may be taking place near the $124 support region, an area that aligns with both the Value Area Low and a key high-time-frame demand zone.

While the broader trend has yet to fully reverse, the structure forming on the chart indicates that bearish momentum is weakening and that buyers are becoming more active.

Solana price key technical points

$124, High-time-frame support and accumulation zone
Value Area Low (VAL), Acting as dynamic support during consolidation
Point of Control (POC), Key resistance that must be reclaimed

SOLUSDT (1D) Chart, Source: TradingView
Solana’s recent behavior is notable for its repeated defenses of the $124 region. Price has retested this level multiple times, and each test has been met with impulsive bullish reactions rather than continuation lower. These reactions suggest that demand is present and active, a key ingredient for accumulation.

From a volume-profile perspective, Solana is currently trading just above the Value Area Low, an area where price is often considered discounted relative to recent trading activity. When markets spend extended time near the lower end of value while failing to break down, it often indicates that sellers are losing control and that stronger hands are absorbing supply.

Importantly, Solana has not produced a decisive close below $124, despite multiple attempts. Failed breakdowns are significant because they often trap late sellers and force short covering once price stabilizes. The last two downside tests have been clearly defended by buyers, reinforcing the idea that $124 is becoming a structurally important level.

However, while accumulation appears to be forming, confirmation is still required. The most critical level overhead is the Point of Control (POC), which represents the highest traded volume within the recent range. The POC often acts as a pivot between bearish and bullish control. As long as Solana remains below this level, rallies risk being corrective rather than impulsive.

A clean reclaim of the POC on a closing basis, backed by strong volume, would signal acceptance back into value and confirm that accumulation has transitioned into expansion. Such a move would likely trigger a rotation toward the next major resistance at $167, where high-time-frame supply is expected to emerge.

From a market-structure standpoint, Solana is attempting to form a base after a prolonged downtrend. Accumulation phases are often characterized by sideways price action, declining volatility, and repeated defenses of support, all of which are currently visible on the chart.

This constructive setup is forming alongside growing fundamental interest, as Solana’s revenue continues to close the gap with Ethereum and investors increasingly explore structured-yield platforms such as SolStaking, which increases the probability of a trend shift if key levels are reclaimed.

Volume behavior remains the missing piece. While bullish reactions have been present, overall participation has been moderate. A successful reversal requires expanding volume, particularly during any breakout attempt above the POC. Without volume confirmation, price risks remain trapped in a broader consolidation range.

What to expect in the coming price action
As long as Solana holds above $124 and continues to defend the Value Area Low, accumulation is likely to persist. The next major signal to watch is a strong, high-volume reclaim of the Point of Control, which would open the door for a rotation toward $167.

Until that occurs, price may continue to consolidate, building pressure for a larger directional move.
2025-12-30 16:06 3mo ago
2025-12-30 11:05 3mo ago
$2B Flows into Crypto Derivatives; Bitcoin and Ethereum Lead Gains cryptonews
BTC ETH
17h05 ▪
4
min read ▪ by
Ifeoluwa O.

Summarize this article with:

Despite broad market caution and a sharp slowdown in trading, derivatives data indicates that investor confidence held firm in December. Overall market activity dropped roughly 40%, yet total derivatives open interest still grew by about $2 billion, with Bitcoin and Ethereum futures accounting for a notable portion. This pushed combined exposure in these two cryptocurrencies from $35 billion to $38 billion and reflected a moderate increase in leverage. The trend suggests that, rather than panic selling, experienced traders continued building positions, likely anticipating a market rebound or increased volatility.

In brief

Open interest rose $2.8B in December, with Bitcoin and Ethereum futures contributing a significant portion.
Bitcoin futures positions grew from $22B to $23B, while Ethereum futures climbed from $13B to $15B.

Bitcoin and Ethereum Futures See Notable Gains
A contributor at on-chain analytics platform CryptoQuant reported that Bitcoin futures positions grew from $22 billion to $23 billion, increasing by $1 billion, while Ethereum futures rose from $13 billion to $15 billion, gaining around $1.4 billion. These changes occurred as Bitcoin’s price hovered near $88,000 and the Crypto Fear and Greed Index remained at 27, reflecting ongoing market caution. Since then, the index has dropped further to 23, a level classified as extreme fear, highlighting the gap between growing derivatives exposure and negative market sentiment.

Bitcoin Open Interest 24H Change on Binance & Bybit (Nov–Dec)
Over the past week, roughly $450 million in new leveraged positions were added, reflecting strong engagement in the derivatives market. This surge in activity occurred even as Bitcoin briefly climbed back to $90,000 yesterday before dropping about $4,000 within six hours, which triggered roughly $100 million in liquidated long positions. Despite this short-term volatility, total Bitcoin positions still rose about 2% week-on-week, suggesting that traders used the pullback as an opportunity to open new positions rather than exit the market.

Here are some other key factors from December that show how traders responded despite market caution:

Centralized exchanges such as Binance, Bybit, and OKX steadily added positions throughout December, with Gate.io showing the largest accumulation, reflecting continued market engagement.
Rather than cutting back, exchanges either held or increased their exposure, a move that differs from the usual pattern where leverage declines during market bottoms.
This sustained growth in open interest, even as fear levels reached extremes, suggests traders remained cautiously optimistic, taking on risk while the broader market sentiment stayed negative.

Investor Outflows Signal Lingering Sentiment Pressure
While derivatives show conviction, broader investment products highlight ongoing caution. CoinShares’ weekly report indicates Bitcoin outflows of $443 million in the past week, while digital asset products overall recorded withdrawals of $446 million. Since the October 10 price drop, cumulative outflows total around $3.2 billion, signaling that investor sentiment has yet to fully recover.

As the year closes, Bitcoin is down 6.51% year-to-date. For the past two weeks, the cryptocurrency has traded in a tight range between $86,700 and $89,900, with small candlesticks pointing to low volatility. To finish the year in positive territory, Bitcoin needs a 6.8% rally from its current $87,240 level. This requires breaking above immediate resistance at $88,000 and pushing past the upper Bollinger Band near $91,000, signaling stronger bullish momentum. 

Bitcoin Price Analysis with Bollinger Bands & RSI
The RSI, around 43, must climb above 50 to confirm upward pressure, supported by consistent buying. Maintaining support near $85,000 is also crucial to avoid further downside. A steady rally with rising momentum and solid support is essential for Bitcoin to close the year in the green.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Ifeoluwa O.

Ifeoluwa specializes in Web3 writing and marketing, with over 5 years of experience creating insightful and strategic content. Beyond this, he trades crypto and is skilled at conducting technical, fundamental, and on-chain analyses.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It stocknewsapi
NVAX
Novavax (NVAX - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this vaccine maker have returned +1.9%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Novavax falls in, has lost 0.1%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Novavax is expected to post a loss of $0.66 per share for the current quarter, representing a year-over-year change of -29.4%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

The consensus earnings estimate of $1.94 for the current fiscal year indicates a year-over-year change of +257.7%. This estimate has remained unchanged over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $0.23 indicates a change of -112.3% from what Novavax is expected to report a year ago. Over the past month, the estimate has changed -36.9%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Novavax.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Novavax, the consensus sales estimate for the current quarter of $78.41 million indicates a year-over-year change of -11.2%. For the current and next fiscal years, $1.05 billion and $308.43 million estimates indicate +54.6% and -70.8% changes, respectively.

Last Reported Results and Surprise HistoryNovavax reported revenues of $70.44 million in the last reported quarter, representing a year-over-year change of -16.6%. EPS of -$0.62 for the same period compares with -$0.76 a year ago.

Compared to the Zacks Consensus Estimate of $39.61 million, the reported revenues represent a surprise of +77.85%. The EPS surprise was +42.59%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Novavax is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Novavax. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Enphase Energy, Inc. (ENPH) Is a Trending Stock: Facts to Know Before Betting on It stocknewsapi
ENPH
Enphase Energy (ENPH - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this solar technology company have returned +15.9%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Solar industry, which Enphase Energy falls in, has lost 0.1%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Enphase Energy is expected to post earnings of $0.52 per share for the current quarter, representing a year-over-year change of -44.7%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

For the current fiscal year, the consensus earnings estimate of $2.77 points to a change of +16.9% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $2.05 indicates a change of -26.2% from what Enphase Energy is expected to report a year ago. Over the past month, the estimate has changed -1.9%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Enphase Energy is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Enphase Energy, the consensus sales estimate of $331.97 million for the current quarter points to a year-over-year change of -13.3%. The $1.46 billion and $1.22 billion estimates for the current and next fiscal years indicate changes of +9.7% and -16.3%, respectively.

Last Reported Results and Surprise HistoryEnphase Energy reported revenues of $410.43 million in the last reported quarter, representing a year-over-year change of +7.8%. EPS of $0.9 for the same period compares with $0.65 a year ago.

Compared to the Zacks Consensus Estimate of $361.79 million, the reported revenues represent a surprise of +13.44%. The EPS surprise was +45.16%.

Over the last four quarters, Enphase Energy surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Enphase Energy is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Enphase Energy. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Palo Alto Networks, Inc. (PANW) is Attracting Investor Attention: Here is What You Should Know stocknewsapi
PANW
Palo Alto Networks (PANW - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this security software maker have returned -0.5%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Security industry, which Palo Alto falls in, has lost 3.2%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Palo Alto is expected to post earnings of $0.93 per share, indicating a change of +14.8% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.4% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $3.84 points to a change of +15% from the prior year. Over the last 30 days, this estimate has changed -0.2%.

For the next fiscal year, the consensus earnings estimate of $4.3 indicates a change of +12% from what Palo Alto is expected to report a year ago. Over the past month, the estimate has changed -0.2%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Palo Alto is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Palo Alto, the consensus sales estimate of $2.58 billion for the current quarter points to a year-over-year change of +14.3%. The $10.52 billion and $11.92 billion estimates for the current and next fiscal years indicate changes of +14.1% and +13.3%, respectively.

Last Reported Results and Surprise HistoryPalo Alto reported revenues of $2.47 billion in the last reported quarter, representing a year-over-year change of +15.7%. EPS of $0.93 for the same period compares with $0.78 a year ago.

Compared to the Zacks Consensus Estimate of $2.46 billion, the reported revenues represent a surprise of +0.52%. The EPS surprise was +4.49%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Palo Alto is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Palo Alto. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Investors Heavily Search Brinker International, Inc. (EAT): Here is What You Need to Know stocknewsapi
EAT
Brinker International (EAT - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Shares of this operator of restaurant chains Chili's Grill & Bar and Maggiano's Little Italy have returned -5.3% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Retail - Restaurants industry, to which Brinker International belongs, has lost 0.1% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Brinker International is expected to post earnings of $2.51 per share, indicating a change of -10.4% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.6% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $10.23 points to a change of +14.9% from the prior year. Over the last 30 days, this estimate has changed +0.3%.

For the next fiscal year, the consensus earnings estimate of $11.74 indicates a change of +14.8% from what Brinker International is expected to report a year ago. Over the past month, the estimate has changed +0.3%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Brinker International is rated Zacks Rank #2 (Buy).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Brinker International, the consensus sales estimate of $1.4 billion for the current quarter points to a year-over-year change of +3.1%. The $5.73 billion and $6.02 billion estimates for the current and next fiscal years indicate changes of +6.5% and +5.1%, respectively.

Last Reported Results and Surprise HistoryBrinker International reported revenues of $1.35 billion in the last reported quarter, representing a year-over-year change of +18.5%. EPS of $1.93 for the same period compares with $0.95 a year ago.

Compared to the Zacks Consensus Estimate of $1.33 billion, the reported revenues represent a surprise of +1.21%. The EPS surprise was +9.66%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Brinker International is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Brinker International. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Investors Heavily Search Nextracker Inc. (NXT): Here is What You Need to Know stocknewsapi
NXT
Nextracker (NXT - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this solar energy equipment supplier have returned +3.2% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Solar industry, to which Nextracker belongs, has lost 0.1% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Nextracker is expected to post earnings of $0.93 per share for the current quarter, representing a year-over-year change of -9.7%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

The consensus earnings estimate of $4.15 for the current fiscal year indicates a year-over-year change of -1.7%. This estimate has remained unchanged over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $4.47 indicates a change of +7.6% from what Nextracker is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Nextracker.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Nextracker, the consensus sales estimate of $808.49 million for the current quarter points to a year-over-year change of +19%. The $3.39 billion and $3.67 billion estimates for the current and next fiscal years indicate changes of +14.6% and +8.3%, respectively.

Last Reported Results and Surprise HistoryNextracker reported revenues of $905.27 million in the last reported quarter, representing a year-over-year change of +42.4%. EPS of $1.19 for the same period compares with $0.97 a year ago.

Compared to the Zacks Consensus Estimate of $827.34 million, the reported revenues represent a surprise of +9.42%. The EPS surprise was +20.2%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Nextracker is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Nextracker. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
monday.com Ltd. (MNDY) is Attracting Investor Attention: Here is What You Should Know stocknewsapi
MNDY
Monday.com (MNDY - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Shares of this project management software developer have returned -3% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Internet - Software industry, to which Monday.com belongs, has gained 2.2% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Monday.com is expected to post earnings of $0.91 per share for the current quarter, representing a year-over-year change of -15.7%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

For the current fiscal year, the consensus earnings estimate of $4.28 points to a change of +22.3% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $4.96 indicates a change of +16% from what Monday.com is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Monday.com.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Monday.com, the consensus sales estimate for the current quarter of $328.99 million indicates a year-over-year change of +22.8%. For the current and next fiscal years, $1.23 billion and $1.49 billion estimates indicate +26.2% and +21.4% changes, respectively.

Last Reported Results and Surprise HistoryMonday.com reported revenues of $316.86 million in the last reported quarter, representing a year-over-year change of +26.2%. EPS of $1.16 for the same period compares with $0.85 a year ago.

Compared to the Zacks Consensus Estimate of $312.02 million, the reported revenues represent a surprise of +1.55%. The EPS surprise was +30.34%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Monday.com is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Monday.com. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Is Trending Stock Salesforce Inc. (CRM) a Buy Now? stocknewsapi
CRM
Salesforce.com (CRM - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this customer-management software developer have returned +14.4%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Computer - Software industry, which Salesforce.com falls in, has gained 0.5%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Salesforce.com is expected to post earnings of $3.05 per share, indicating a change of +9.7% from the year-ago quarter. The Zacks Consensus Estimate has changed -4% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $11.74 points to a change of +15.1% from the prior year. Over the last 30 days, this estimate has changed +4.1%.

For the next fiscal year, the consensus earnings estimate of $12.97 indicates a change of +10.5% from what Salesforce.com is expected to report a year ago. Over the past month, the estimate has changed +2.6%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Salesforce.com is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Salesforce.com, the consensus sales estimate of $11.19 billion for the current quarter points to a year-over-year change of +11.9%. The $41.49 billion and $45.99 billion estimates for the current and next fiscal years indicate changes of +9.5% and +10.9%, respectively.

Last Reported Results and Surprise HistorySalesforce.com reported revenues of $10.26 billion in the last reported quarter, representing a year-over-year change of +8.6%. EPS of $3.25 for the same period compares with $2.41 a year ago.

Compared to the Zacks Consensus Estimate of $10.26 billion, the reported revenues represent a surprise of -0.05%. The EPS surprise was +14.04%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Salesforce.com is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Salesforce.com. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Investors Heavily Search American Eagle Outfitters, Inc. (AEO): Here is What You Need to Know stocknewsapi
AEO
American Eagle Outfitters (AEO - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this teen clothing retailer have returned +26.7% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Retail - Apparel and Shoes industry, to which American Eagle belongs, has gained 8.8% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

American Eagle is expected to post earnings of $0.66 per share for the current quarter, representing a year-over-year change of +22.2%. Over the last 30 days, the Zacks Consensus Estimate has changed +19.1%.

For the current fiscal year, the consensus earnings estimate of $1.33 points to a change of -23.6% from the prior year. Over the last 30 days, this estimate has changed +18.2%.

For the next fiscal year, the consensus earnings estimate of $1.58 indicates a change of +18.8% from what American Eagle is expected to report a year ago. Over the past month, the estimate has changed +15.3%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for American Eagle.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For American Eagle, the consensus sales estimate for the current quarter of $1.72 billion indicates a year-over-year change of +7.4%. For the current and next fiscal years, $5.46 billion and $5.6 billion estimates indicate +2.4% and +2.6% changes, respectively.

Last Reported Results and Surprise HistoryAmerican Eagle reported revenues of $1.36 billion in the last reported quarter, representing a year-over-year change of +5.7%. EPS of $0.53 for the same period compares with $0.48 a year ago.

Compared to the Zacks Consensus Estimate of $1.32 billion, the reported revenues represent a surprise of +3.31%. The EPS surprise was +23.26%.

Over the last four quarters, American Eagle surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

American Eagle is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about American Eagle. However, its Zacks Rank #1 does suggest that it may outperform the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Here is What to Know Beyond Why EMCOR Group, Inc. (EME) is a Trending Stock stocknewsapi
EME
Emcor Group (EME - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this construction and maintenance company have returned +2.6%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Building Products - Heavy Construction industry, which Emcor Group falls in, has gained 1.6%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Emcor Group is expected to post earnings of $6.66 per share, indicating a change of +5.4% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

The consensus earnings estimate of $25.24 for the current fiscal year indicates a year-over-year change of +17.3%. This estimate has remained unchanged over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $27.41 indicates a change of +8.6% from what Emcor Group is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Emcor Group is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Emcor Group, the consensus sales estimate for the current quarter of $4.27 billion indicates a year-over-year change of +13.3%. For the current and next fiscal years, $16.75 billion and $17.73 billion estimates indicate +15% and +5.9% changes, respectively.

Last Reported Results and Surprise HistoryEmcor Group reported revenues of $4.3 billion in the last reported quarter, representing a year-over-year change of +16.4%. EPS of $6.57 for the same period compares with $5.8 a year ago.

Compared to the Zacks Consensus Estimate of $4.32 billion, the reported revenues represent a surprise of -0.37%. The EPS surprise was -1.2%.

Over the last four quarters, Emcor Group surpassed consensus EPS estimates three times. The company topped consensus revenue estimates two times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Emcor Group is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Emcor Group. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
ON Semiconductor Corporation (ON) is Attracting Investor Attention: Here is What You Should Know stocknewsapi
ON
ON Semiconductor Corp. (ON - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this semiconductor components maker have returned +7.1% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Semiconductor - Analog and Mixed industry, to which ON Semiconductor Corp. belongs, has gained 6.5% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, ON Semiconductor Corp. is expected to post earnings of $0.62 per share, indicating a change of -34.7% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $2.36 points to a change of -40.7% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $2.9 indicates a change of +23.1% from what ON Semiconductor Corp. is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, ON Semiconductor Corp. is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of ON Semiconductor Corp., the consensus sales estimate of $1.53 billion for the current quarter points to a year-over-year change of -11%. The $5.99 billion and $6.3 billion estimates for the current and next fiscal years indicate changes of -15.4% and +5%, respectively.

Last Reported Results and Surprise HistoryON Semiconductor Corp. reported revenues of $1.55 billion in the last reported quarter, representing a year-over-year change of -12%. EPS of $0.63 for the same period compares with $0.99 a year ago.

Compared to the Zacks Consensus Estimate of $1.52 billion, the reported revenues represent a surprise of +2.36%. The EPS surprise was +5%.

Over the last four quarters, ON Semiconductor Corp. surpassed consensus EPS estimates two times. The company topped consensus revenue estimates three times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

ON Semiconductor Corp. is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about ON Semiconductor Corp.. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Alphabet Inc. (GOOG) is Attracting Investor Attention: Here is What You Should Know stocknewsapi
GOOG GOOGL
Alphabet Inc. (GOOG - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this company have returned -0.2% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Internet - Services industry, to which Alphabet belongs, has lost 1.6% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Alphabet is expected to post earnings of $2.59 per share for the current quarter, representing a year-over-year change of +20.5%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.1%.

For the current fiscal year, the consensus earnings estimate of $10.58 points to a change of +31.6% from the prior year. Over the last 30 days, this estimate has changed +0.1%.

For the next fiscal year, the consensus earnings estimate of $11.04 indicates a change of +4.3% from what Alphabet is expected to report a year ago. Over the past month, the estimate has changed +0.5%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Alphabet is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Alphabet, the consensus sales estimate of $94.6 billion for the current quarter points to a year-over-year change of +15.9%. The $340.26 billion and $390.18 billion estimates for the current and next fiscal years indicate changes of +15.3% and +14.7%, respectively.

Last Reported Results and Surprise HistoryAlphabet reported revenues of $87.47 billion in the last reported quarter, representing a year-over-year change of +17.3%. EPS of $2.87 for the same period compares with $2.12 a year ago.

Compared to the Zacks Consensus Estimate of $84.96 billion, the reported revenues represent a surprise of +2.95%. The EPS surprise was +26.99%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Alphabet is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Alphabet. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Is Trending Stock Medical Properties Trust, Inc. (MPW) a Buy Now? stocknewsapi
MPW
Medical Properties (MPW - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this health care real estate investment trust have returned -9.4% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks REIT and Equity Trust - Other industry, to which Medical Properties belongs, has lost 3.5% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Medical Properties is expected to post earnings of $0.15 per share for the current quarter, representing a year-over-year change of -16.7%. Over the last 30 days, the Zacks Consensus Estimate has changed -3.3%.

For the current fiscal year, the consensus earnings estimate of $0.55 points to a change of -31.3% from the prior year. Over the last 30 days, this estimate has changed -1.4%.

For the next fiscal year, the consensus earnings estimate of $0.66 indicates a change of +20% from what Medical Properties is expected to report a year ago. Over the past month, the estimate has changed -2.9%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Medical Properties.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Medical Properties, the consensus sales estimate of $242.96 million for the current quarter points to a year-over-year change of +4.8%. The $944.64 million and $1.03 billion estimates for the current and next fiscal years indicate changes of -5.1% and +9.4%, respectively.

Last Reported Results and Surprise HistoryMedical Properties reported revenues of $237.52 million in the last reported quarter, representing a year-over-year change of +5.2%. EPS of -$0.13 for the same period compares with -$1.34 a year ago.

Compared to the Zacks Consensus Estimate of $237.84 million, the reported revenues represent a surprise of -0.13%. The EPS surprise was -18.75%.

Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates two times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Medical Properties is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Medical Properties. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Here is What to Know Beyond Why JPMorgan Chase & Co. (JPM) is a Trending Stock stocknewsapi
JPM
JPMorgan Chase & Co. (JPM - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this company have returned +4.8% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Financial - Investment Bank industry, to which JPMorgan Chase & Co. belongs, has gained 5.4% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

JPMorgan Chase & Co. is expected to post earnings of $4.97 per share for the current quarter, representing a year-over-year change of +3.3%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.5%.

The consensus earnings estimate of $20.33 for the current fiscal year indicates a year-over-year change of +2.9%. This estimate has changed +0.3% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $21.01 indicates a change of +3.3% from what JPMorgan Chase & Co. is expected to report a year ago. Over the past month, the estimate has changed -0.9%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, JPMorgan Chase & Co. is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For JPMorgan Chase & Co., the consensus sales estimate for the current quarter of $45.65 billion indicates a year-over-year change of +6.8%. For the current and next fiscal years, $182.53 billion and $189.63 billion estimates indicate +2.8% and +3.9% changes, respectively.

Last Reported Results and Surprise HistoryJPMorgan Chase & Co. reported revenues of $46.43 billion in the last reported quarter, representing a year-over-year change of +8.8%. EPS of $5.07 for the same period compares with $4.37 a year ago.

Compared to the Zacks Consensus Estimate of $44.86 billion, the reported revenues represent a surprise of +3.51%. The EPS surprise was +4.97%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

JPMorgan Chase & Co. is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about JPMorgan Chase & Co.. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Builders FirstSource, Inc. (BLDR) is Attracting Investor Attention: Here is What You Should Know stocknewsapi
BLDR
Builders FirstSource (BLDR - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Over the past month, shares of this construction supply company have returned -8.6%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Building Products - Retail industry, which Builders FirstSource falls in, has gained 17.8%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Builders FirstSource is expected to post earnings of $1.31 per share, indicating a change of -43.3% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

The consensus earnings estimate of $7.07 for the current fiscal year indicates a year-over-year change of -38.8%. This estimate has remained unchanged over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $6.19 indicates a change of -12.5% from what Builders FirstSource is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Builders FirstSource is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Builders FirstSource, the consensus sales estimate for the current quarter of $3.44 billion indicates a year-over-year change of -9.9%. For the current and next fiscal years, $15.27 billion and $14.98 billion estimates indicate -6.9% and -1.9% changes, respectively.

Last Reported Results and Surprise HistoryBuilders FirstSource reported revenues of $3.94 billion in the last reported quarter, representing a year-over-year change of -6.9%. EPS of $1.88 for the same period compares with $3.07 a year ago.

Compared to the Zacks Consensus Estimate of $3.8 billion, the reported revenues represent a surprise of +3.76%. The EPS surprise was +11.24%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates just once over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Builders FirstSource is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Builders FirstSource. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
PayPal Holdings, Inc. (PYPL) Is a Trending Stock: Facts to Know Before Betting on It stocknewsapi
PYPL
Paypal (PYPL - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this technology platform and digital payments company have returned -4.9%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Financial Transaction Services industry, which Paypal falls in, has gained 4.7%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Paypal is expected to post earnings of $1.29 per share, indicating a change of +8.4% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.2% over the last 30 days.

The consensus earnings estimate of $5.34 for the current fiscal year indicates a year-over-year change of +14.8%. This estimate has changed -0.1% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $5.86 indicates a change of +9.7% from what Paypal is expected to report a year ago. Over the past month, the estimate has changed -0.2%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Paypal is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Paypal, the consensus sales estimate for the current quarter of $8.81 billion indicates a year-over-year change of +5.3%. For the current and next fiscal years, $33.29 billion and $35.17 billion estimates indicate +4.7% and +5.7% changes, respectively.

Last Reported Results and Surprise HistoryPaypal reported revenues of $8.42 billion in the last reported quarter, representing a year-over-year change of +7.3%. EPS of $1.34 for the same period compares with $1.2 a year ago.

Compared to the Zacks Consensus Estimate of $8.26 billion, the reported revenues represent a surprise of +1.95%. The EPS surprise was +12.61%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Paypal is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Paypal. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Apple Inc. (AAPL) Is a Trending Stock: Facts to Know Before Betting on It stocknewsapi
AAPL
Apple (AAPL - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this maker of iPhones, iPads and other products have returned -3.3% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Computer - Micro Computers industry, to which Apple belongs, has lost 1.9% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Apple is expected to post earnings of $2.65 per share, indicating a change of +10.4% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $8.11 points to a change of +8.7% from the prior year. Over the last 30 days, this estimate has changed -0.1%.

For the next fiscal year, the consensus earnings estimate of $9.12 indicates a change of +12.4% from what Apple is expected to report a year ago. Over the past month, the estimate has changed +0.4%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Apple.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Apple, the consensus sales estimate for the current quarter of $137.51 billion indicates a year-over-year change of +10.6%. For the current and next fiscal years, $451.74 billion and $489.78 billion estimates indicate +8.5% and +8.4% changes, respectively.

Last Reported Results and Surprise HistoryApple reported revenues of $102.47 billion in the last reported quarter, representing a year-over-year change of +7.9%. EPS of $1.85 for the same period compares with $1.64 a year ago.

Compared to the Zacks Consensus Estimate of $101.2 billion, the reported revenues represent a surprise of +1.25%. The EPS surprise was +6.94%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Apple is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Apple. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock stocknewsapi
CRSP
CRISPR Therapeutics AG (CRSP - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Shares of this company have returned +3.5% over the past month versus the Zacks S&P 500 composite's +0.9% change. The Zacks Medical - Biomedical and Genetics industry, to which CRISPR Therapeutics belongs, has lost 0.1% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

CRISPR Therapeutics is expected to post a loss of $1.16 per share for the current quarter, representing a year-over-year change of -163.6%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.2%.

The consensus earnings estimate of -$6.34 for the current fiscal year indicates a year-over-year change of -46.1%. This estimate has changed +0.3% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $4.13 indicates a change of +34.7% from what CRISPR Therapeutics is expected to report a year ago. Over the past month, the estimate has changed -1.2%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, CRISPR Therapeutics is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For CRISPR Therapeutics, the consensus sales estimate for the current quarter of $4 million indicates a year-over-year change of -88.8%. For the current and next fiscal years, $8.54 million and $182.32 million estimates indicate -77.1% and +2035.9% changes, respectively.

Last Reported Results and Surprise HistoryCRISPR Therapeutics reported revenues of $0.89 million in the last reported quarter, representing a year-over-year change of +48.3%. EPS of -$1.17 for the same period compares with -$1.01 a year ago.

Compared to the Zacks Consensus Estimate of $6.71 million, the reported revenues represent a surprise of -86.76%. The EPS surprise was +11.36%.

Over the last four quarters, CRISPR Therapeutics surpassed consensus EPS estimates three times. The company topped consensus revenue estimates just once over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

CRISPR Therapeutics is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about CRISPR Therapeutics. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
LEU Enrichment Scale-Up: A Win for U.S. Energy Independence? stocknewsapi
LEU
Key Takeaways LEU starts centrifuge manufacturing at its Piketon, OH, site to support commercial low-enriched uranium.LEU plans to expand Piketon with potential DOE funding and private capital.LEU has $2.3B in contingent contracts and raised $1.2B via convertibles, plus a $1B at-the-market offering.
Centrus Energy LEU has officially begun industrial-scale centrifuge manufacturing to support commercial Low-Enriched Uranium enrichment activities at its Piketon, OH, facility. This marks a pivotal milestone in the American nuclear fuel supply chain, which has lacked domestically owned large-scale enrichment capability for more than a decade.

The last U.S.-owned, large-scale uranium enrichment plant was constructed in the 1950s but shut down in 2013, leaving the United States heavily reliant on foreign, state-owned enterprises that dominate global enrichment capacity. With imports of Russian enriched uranium banned starting in 2028, Centrus Energy’s endeavors address the urgent and growing need for secure, U.S.-owned enrichment capacity.

Centrus Energy is strategically moving ahead to expand its uranium enrichment plant in Piketon to support the production of both Low-Enriched Uranium and High-Assay, Low-Enriched Uranium (HALEU). The company is already a leading contender for funding from the Department of Energy, with potential task orders indicated at approximately $900 million each.

Centrus Energy raised $1.2 billion via convertible note transactions in November 2024 and August 2025 and recently launched a $1 billion at-the-market offering.  The company also signed a Memorandum of Understanding (MOU) with Korea Hydro & Nuclear Power (“KHNP”) and POSCO International, a subsidiary of POSCO (PKX - Free Report) , attracting foreign investment. 

Beyond capital support, the collaboration with KHNP and POSCO creates strategic opportunities, such as additional supply agreements for Low-Enriched Uranium and HALEU. Notably, POSCO International is also advancing a next-generation High-Temperature Gas Reactor powered by HALEU.
Centrus Energy already has $2.3 billion in contracts in place from both domestic and international customers to support new U.S. uranium enrichment capacity.  These agreements are, however, contingent upon it achieving key milestones toward building the new capacity. 

LEU’s Price Performance, Valuation & EstimatesCentrus Energy shares have soared 272.9% in a year compared with the industry’s 49% growth.

Image Source: Zacks Investment Research

Meanwhile, peer Energy Fuels (UUUU - Free Report) has gained 195% in a year. Lakewood, CO-based Energy Fuels owns and operates several conventional and in-situ uranium projects in the western US, as well as the White Mesa Mill, which is the only operating conventional uranium mill in the United States. 

LEU is trading at a forward 12-month price/sales multiple of 9.25X, a significant premium to the industry’s 4.11X. Energy Fuels is trading higher at 40.01X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Centrus Energy’s 2025 earnings is pegged at $4.66 per share, indicating 4.25% year-over-year growth. The same for 2026 is $3.85, indicating a decline of 17.2%. Here is how the EPS estimates for 2025 and 2026 have been revised over the past 60 days.

Image Source: Zacks Investment Research

The company currently carries a Zacks Rank #3 (Hold).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2025-12-30 15:06 3mo ago
2025-12-30 10:01 3mo ago
These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar stocknewsapi
CRGY SHEL
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The earnings figure itself is key, of course, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb and vice versa.

The ability to identify stocks that are likely to top quarterly earnings expectations can be profitable, but it's no simple task. Here at Zacks, our Earnings ESP filter helps make things easier.

The Zacks Earnings ESP, ExplainedThe Zacks Expected Surprise Prediction, or ESP, works by locking in on the most up-to-date analyst earnings revisions because they can be more accurate than estimates from weeks or even months before the actual release date. The thinking is pretty straightforward: analysts who provide earnings estimates closer to the report are likely to have more information.

The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction. The Zacks Rank is also factored into the ESP metric to better help find companies that appear poised to top their next bottom-line consensus estimate, which will hopefully help lift the stock price.

In fact, when we combined a Zacks Rank #3 (Hold) or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time. Perhaps most importantly, using these parameters has helped produce 28.3% annual returns on average, according to our 10 year backtest.

Most stocks, about 60%, fall into the #3 (Hold) category, and they are expected to perform in-line with the broader market. Stocks with a #2 (Buy) and #1 (Strong Buy) rating, or the top 15% and top 5% of stocks, respectively, should outperform the market, with Strong Buy stocks outperforming more than any other rank.

Should You Consider Shell?The last thing we will do today, now that we have a grasp on the ESP and how powerful of a tool it can be, is to quickly look at a qualifying stock. Shell (SHEL - Free Report) holds a #3 (Hold) at the moment and its Most Accurate Estimate comes in at $1.40 a share 30 days away from its upcoming earnings release on January 29, 2026.

Shell's Earnings ESP sits at +1.83%, which, as explained above, is calculated by taking the percentage difference between the $1.40 Most Accurate Estimate and the Zacks Consensus Estimate of $1.37. SHEL is also part of a large group of stocks that boast a positive ESP. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

SHEL is just one of a large group of Oils and Energy stocks with a positive ESP figure. Crescent Energy (CRGY - Free Report) is another qualifying stock you may want to consider.

Slated to report earnings on February 25, 2026, Crescent Energy holds a #3 (Hold) ranking on the Zacks Rank, and its Most Accurate Estimate is $0.24 a share 57 days from its next quarterly update.

The Zacks Consensus Estimate for Crescent Energy is $0.19, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of +29.73%.

SHEL and CRGY's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon.

Find Stocks to Buy or Sell Before They're ReportedUse the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>